OriginClear (OCLN) 10-Q 15 Aug 22 2022 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2022	Aug. 15, 2022
Document Information Line Items
Entity Registrant Name	ORIGINCLEAR, INC.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		813,095,477
Amendment Flag	false
Entity Central Index Key	0001419793
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Jun. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	333-147980
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	26-0287664
Entity Address, Address Line One	13575 58th Street North
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Clearwater
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33760
City Area Code	(727)
Local Phone Number	440-4603
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
CURRENT ASSETS
Cash	$ 634,677	$ 272,470
Restricted cash	1,066,391	433,951
Contracts receivable	1,389,291	2,150,967
Fair value investment in securities	67,813	198,918
Contract assets	1,103,907	378,932
Inventory assets	18,025	2,850
Prepaid expenses	11,615	13,111
TOTAL CURRENT ASSETS	4,291,719	3,451,199
NET PROPERTY AND EQUIPMENT	192,149	213,391
OTHER ASSETS
Long term assets held for sale	514,000	514,000
Fair value investment-securities	6,000	17,600
Trademark	4,467	4,467
TOTAL OTHER ASSETS	524,467	536,067
TOTAL ASSETS	5,008,335	4,200,657
Current Liabilities
Accounts payable and other payable	2,162,601	1,452,229
Accrued expenses	1,566,491	1,533,404
Cumulative preferred stock dividends payable	371,863	356,728
Contract liabilities	1,597,997	1,886,946
Capital lease, current portion	3,441	7,985
Customer deposit	146,453	146,453
Warranty reserve	20,000	20,000
Loan payable, merchant cash advance	30,646	80,646
Loans payable, SBA	150,000	150,000
Derivative liabilities	8,095,027	6,526,129
Series F 8% Preferred Stock, 60 and 160 shares issued and outstanding, redeemable value of $60,000 and $175,000 respectively	60,000	160,000
Series F 8% Preferred Stock, 0 and 100 shares issued and outstanding, respectively redeemable value of $0 and $100,000 respectively		100,000
Series G 8% Preferred Stock, 25 and 25 shares issued and outstanding, respectively, redeemable value of $25,000 and $25,000, respectively	25,000	25,000
Series I 8% Preferred Stock, 25 and 797 shares issued and outstanding, respectively, redeemable value of $25,000 and $235,000, respectively	25,000	235,000
Series K 8% Preferred Stock, 432.15 and 580.65 shares issued and outstanding, respectively, redeemable value of $432,150 and $580,650, respectively	432,150	580,650
Convertible promissory notes, net of discount of $0 and $3,743, respectively	878,283	3,016,037
Total Current Liabilities	15,564,952	16,277,207
Long Term Liabilities
Capital lease, long term portion
Convertible promissory notes, net of discount of $0 and $0, respectively	2,133,872	62,275
Total Long Term Liabilities	2,133,872	62,275
Total Liabilities	17,698,824	16,339,482
COMMITMENTS AND CONTINGENCIES (See Note 11)
Convertible preferred stock, total	12,177,450	10,183,092
SHAREHOLDERS’ DEFICIT
Preferred stock, $0.0001 par value, 550,000,000 shares authorized 1,000 shares of Series C issued and outstanding, respectively
31,500,000 and 32,500,000 shares of Series D-1 issued and outstanding, respectively	3,150	3,150
1,537,213 shares of Series E issued and outstanding, respectively	154	154
Subscription payable to purchase	100,000	100,000
Preferred treasury stock,1,000 and 1,000 shares outstanding, respectively
Common stock, $0.0001 par value, 16,000,000,000 shares authorized 607,030,697 and 306,883,932 equity shares issued and outstanding, respectively	60,703	30,688
Additional paid in capital - Common stock	77,986,132	75,720,147
Accumulated other comprehensive loss	(132)	(132)
Accumulated deficit	(103,017,946)	(98,175,924)
TOTAL SHAREHOLDERS’ DEFICIT	(24,867,939)	(22,321,917)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	5,008,335	4,200,657
Series J Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	210,000	215,000
Series L Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	475,750	609,825
Series M Preferred Stock
Long Term Liabilities
Convertible preferred stock	1,007,500	1,007,500
Series O 8% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	615,000	615,000
Series P Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	57,500	57,500
Series Q 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	715,000	515,000
Series R 10% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	3,034,000	3,432,267
Series S 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	170,000	170,000
Series T 10% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	286,000	630,000
Series U Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	635,000	1,066,500
Series V Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock		400,000
Series W 12% Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	994,500	744,500
Series X Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	250,000	250,000
Series Y Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	3,477,200	470,000
Series Z Convertible Preferred Stock
Long Term Liabilities
Convertible preferred stock	$ 250,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Preferred stock, shares outstanding	19,944
Net of discount current (in Dollars)	$ 0	$ 3,743
Long term net of discount current (in Dollars)	$ 0	$ 0
Preferred treasury stock, shares outstanding	1,000	1,000
Common shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	16,000,000,000	16,000,000,000
Common shares, shares issued	607,030,697	306,883,932
Common shares, shares outstanding	607,030,697	306,883,932
Series F 8% Preferred Stock
Preferred stock, shares issued	60	160
Preferred stock, shares outstanding	60	160
Preferred stock, redeemable value (in Dollars)	$ 60,000	$ 175,000
Series F 8% Convertible Preferred Stock One
Preferred stock, shares issued	0	100
Preferred stock, shares outstanding	0	100
Preferred stock, redeemable value (in Dollars)	$ 0	$ 100,000
Series G 8% Preferred Stock
Preferred stock, shares issued	25	25
Preferred stock, shares outstanding	25	25
Preferred stock, redeemable value (in Dollars)	$ 25,000	$ 25,000
Series I 8% Preferred Stock
Preferred stock, shares issued	25	797
Preferred stock, shares outstanding	25	797
Preferred stock, redeemable value (in Dollars)	$ 25,000	$ 235,000
Series K 8% Preferred Stock
Preferred stock, shares issued	432.15	580.65
Preferred stock, shares outstanding	432.15	580.65
Preferred stock, redeemable value (in Dollars)	$ 432,150	$ 580,650
Series J Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 210,000	$ 215,000
Convertible preferred stock, shares issued	210	215
Convertible preferred stock, shares outstanding	210	215
Series L Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 475.75	$ 609.825
Convertible preferred stock, shares issued	475.75	609.825
Convertible preferred stock, shares outstanding	475.75	609.825
Series M Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 1,007,500	$ 1,007,500
Convertible preferred stock, shares issued	40,300	40,300
Convertible preferred stock, shares outstanding	40,300	40,300
Series O 8% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 615,000	$ 615,000
Convertible preferred stock, shares issued	615	615
Convertible preferred stock, shares outstanding	615	615
Series P Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 57,500	$ 57,500
Convertible preferred stock, shares issued	57.5	57.5
Convertible preferred stock, shares outstanding	57.5	57.5
Series Q 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 715,000	$ 515,000
Convertible preferred stock, shares issued	715	515
Convertible preferred stock, shares outstanding	715	515
Series R 10% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 3,034,000	$ 3,432,267
Convertible preferred stock, shares issued	3,034	3,432.27
Convertible preferred stock, shares outstanding	3,034	3,432.27
Series S 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 170,000	$ 170,000
Convertible preferred stock, shares issued	170	170
Convertible preferred stock, shares outstanding	170	170
Series T 10% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 286,000	$ 630,000
Convertible preferred stock, shares issued	286	630
Convertible preferred stock, shares outstanding	286	630
Series U Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 635,000	$ 1,066,500
Convertible preferred stock, shares issued	635	1,066.5
Convertible preferred stock, shares outstanding	635	1,066.5
Series V Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 0	$ 400,000
Convertible preferred stock, shares issued	0	4
Convertible preferred stock, shares outstanding	0	4
Series W 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 994,500	$ 744,500
Convertible preferred stock, shares issued	994.5	744.5
Convertible preferred stock, shares outstanding	994.5	744.5
Series X Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 250,000	$ 250,000
Convertible preferred stock, shares issued	250	250
Convertible preferred stock, shares outstanding	250	250
Series Y Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 4,183,700	$ 470,000
Convertible preferred stock, shares issued	41.837	4.7
Convertible preferred stock, shares outstanding	41.837	4.7
Series Z Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 250,000	$ 0
Convertible preferred stock, shares issued	25	0
Convertible preferred stock, shares outstanding	25	0
Series C Preferred Stock
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Preferred stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	550,000,000	550,000,000
Series D-1 Preferred Stock
Preferred stock, shares issued	31,500,000	32,500,000
Preferred stock, shares outstanding	31,500,000	32,500,000
Series E Preferred Stock
Preferred stock, shares issued	1,537,213	1,537,213
Preferred stock, shares outstanding	1,537,213	1,537,213

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Sales	$ 3,167,967	$ 931,422	$ 4,402,072	$ 1,727,600
Cost of Goods Sold	2,482,493	754,922	3,941,348	1,446,946
Gross Profit	685,474	176,500	460,724	280,654
Operating Expenses
Selling and marketing expenses	466,566	1,133,056	1,112,750	1,564,564
General and administrative expenses	934,899	961,623	1,815,159	1,779,673
Depreciation and amortization expense	10,509	11,500	21,242	23,131
Total Operating Expenses	1,411,974	2,106,179	2,949,151	3,367,368
Loss from Operations	(726,500)	(1,929,679)	(2,488,427)	(3,086,714)
OTHER INCOME (EXPENSE)
Other income		3,500		3,501
Gain on write of loans payable		6,250	75,000	6,250
Gain (loss) on conversion of preferred stock	(34,988)	(328,472)	(245,985)	(1,119,284)
Loss on exchange of preferred stock				(40,000)
Unrealized gain (loss) on investment securities	(29,927)	(4,800)	(142,705)	40,400
Gain (loss) on net change in derivative liability and conversion of debt	(242,185)	(8,293,128)	(1,568,898)	(23,944,836)
Interest expense	(232,156)	(357,174)	(471,008)	(620,395)
TOTAL OTHER (EXPENSE) INCOME	(539,256)	(8,973,824)	(2,353,596)	(25,674,364)
NET INCOME (LOSS)	(1,265,756)	(10,903,503)	(4,842,023)	(28,761,078)
WARRANTS DEEMED DIVIDENDS				(2,037,849)
NET (LOSS) ATTRIBUTABLE TO SHAREHOLDERS INCOME	$ (1,265,756)	$ (10,903,503)	$ (4,842,023)	$ (30,798,927)
BASIC EARNINGS (LOSS) PER SHARE ATTRIBUTABLE TO SHAREHOLDERS’ (in Dollars per share)	$ 0	$ (0.07)	$ (0.01)	$ (0.25)
DILUTED EARNINGS (LOSS) PER SHARE ATTRIBUTABLE TO SHAREHOLDERS’ (in Dollars per share)	$ 0	$ (0.07)	$ (0.01)	$ (0.25)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC (in Shares)	573,084,370	152,856,918	495,173,641	122,395,397
DILUTED (in Shares)	573,084,370	152,856,918	495,173,641	122,395,397

Consolidated Statements of Shar

Consolidated Statements of Shareholders’ Deficit - USD ($)	Preferred stock	Mezzanine Equity	Common stock	Additional Paid-in- Capital	Subscription Payable	Accumulated Other Comprehensive loss	Accumulated Deficit	Total
Balance at Dec. 31, 2020	$ 3,404	$ 6,331,409	$ 6,505	$ 64,265,217	$ 100,000	$ (132)	$ (94,020,294)	$ (29,645,300)
Balance (in Shares) at Dec. 31, 2020	34,038,213		65,052,688
Rounding
Common stock issuance for conversion of debt and accrued interest			$ 1,393	132,312				133,705
Common stock issuance for conversion of debt and accrued interest (in Shares)			13,927,622
Common stock issued at fair value for services			$ 1,705	1,435,664				1,437,369
Common stock issued at fair value for services (in Shares)			17,045,363
Common stock issued for conversion of Series D1 Preferred stock	$ (100)		$ 7	5,547				5,554
Common stock issued for conversion of Series D1 Preferred stock (in Shares)	(1,000,000)		68,571
Common stock issued for conversion of Series J Preferred stock		(47,500)	$ 120	47,380				47,500
Common stock issued for conversion of Series J Preferred stock (in Shares)			1,203,924
Common stock issued for conversion of Series L Preferred stock		(472,759)	$ 1,527	471,232				472,759
Common stock issued for conversion of Series L Preferred stock (in Shares)			15,265,754
Common stock issued for Series O Preferred stock dividends			$ 33	(33)
Common stock issued for Series O Preferred stock dividends (in Shares)			334,857
Common stock issued for conversion of Series O Preferred stock		(1,040,000)	$ 2,664	1,037,336				1,040,000
Common stock issued for conversion of Series O Preferred stock (in Shares)			26,641,378
Common stock issued for conversion of Series P Preferred stock		(275,250)	$ 864	274,386				275,250
Common stock issued for conversion of Series P Preferred stock (in Shares)			8,639,826
Common stock issued for conversion of Series Q Preferred stock		(210,000)	$ 518	209,482				210,000
Common stock issued for conversion of Series Q Preferred stock (in Shares)			5,180,156
Common stock issued for conversion of Series R Preferred stock		(879,900)	$ 2,474	877,426				879,900
Common stock issued for conversion of Series R Preferred stock (in Shares)			24,738,648
Common stock issued for conversion of Series S Preferred stock		(85,000)	$ 204	84,796				85,000
Common stock issued for conversion of Series S Preferred stock (in Shares)			2,039,206
Issuance of Series M Preferred stock through a private placement		29,425
Issuance of Series R Preferred stock through a private placement		2,480,750
Issuance of Series T Preferred stock in exchange for property		630,000
Issuance of Series U Preferred stock in exchange for property		50,000
Exchange of Series F Preferred Stock for Series Q Preferred stock		15,000
Exchange of Series G Preferred Stock for Series R Preferred stock		15,000
Exchange of Series G Preferred Stock for Series S Preferred stock		365,000
Exchange of Series I Preferred Stock for Series R Preferred stock		317,400
Exchange of Series I Preferred Stock for Series W Preferred stock		150,000
Exchange of Series K Preferred Stock for Series R Preferred stock		1,821,767
Exchange of Series K Preferred Stock for Series W Preferred stock		120,000
Exchange of Series M Preferred Stock for Series R Preferred stock		40,000
Loss on conversion of Preferred stock				1,119,284				1,119,284
Issuance of common stock warrants deemed dividends				2,037,849			(2,037,849)
Adjustment to Series L Preferred stock		500		(500)				(500)
Net Income (loss)							(28,761,078)	(28,761,078)
Balance at Jun. 30, 2021	$ 3,304	9,355,842	$ 18,014	71,997,378	100,000	(132)	(124,819,221)	(52,700,557)
Balance (in Shares) at Jun. 30, 2021	33,038,213		180,137,993
Balance at Dec. 31, 2021	$ 3,304	10,183,092	$ 30,688	75,720,147	100,000	(132)	(98,175,924)	(22,321,917)
Balance (in Shares) at Dec. 31, 2021	33,038,213		306,883,932
Rounding		5	$ 2	(3)			1
Common stock issuance for conversion of debt and accrued interest			$ 1,246	118,388				119,634
Common stock issuance for conversion of debt and accrued interest (in Shares)			12,461,909
Common stock issued at fair value for services			$ 2,485	520,050				522,535
Common stock issued at fair value for services (in Shares)			24,845,550
Common stock issued for conversion of Series J Preferred stock		(5,000)	$ 51	4,949				5,000
Common stock issued for conversion of Series J Preferred stock (in Shares)			512,737
Common stock issued for conversion of Series L Preferred stock		(134,080)	$ 1,598	132,482				134,080
Common stock issued for conversion of Series L Preferred stock (in Shares)			15,973,192
Common stock issued for Series O Preferred stock dividends			$ 72	(72)
Common stock issued for Series O Preferred stock dividends (in Shares)			720,665
Common stock issued for conversion of Series R Preferred stock		(398,267)	$ 2,862	395,405				398,267
Common stock issued for conversion of Series R Preferred stock (in Shares)			28,625,607
Common stock issued for conversion of Series T Preferred stock		(344,000)	$ 5,332	338,668				344,000
Common stock issued for conversion of Series T Preferred stock (in Shares)			53,327,672
Common stock issued for conversion of Series U Preferred stock		(431,500)	$ 2,279	429,221				431,500
Common stock issued for conversion of Series U Preferred stock (in Shares)			22,794,493
Common stock issued for conversion of Series W Preferred stock		(45,000)	$ 381	44,619				45,000
Common stock issued for conversion of Series W Preferred stock (in Shares)			3,811,810
Common stock issued for conversion of Series Y Preferred stock		(50,000)	$ 423	49,577				50,000
Common stock issued for conversion of Series Y Preferred stock (in Shares)			4,230,769
Common stock issued for make good shares for Series P Preferred Stock			$ 52	(52)
Common stock issued for make good shares for Series P Preferred Stock (in Shares)			518,232
Common stock issued for make good shares for Series R Preferred Stock			$ 104	(104)
Common stock issued for make good shares for Series R Preferred Stock (in Shares)			1,041,662
Common stock issued for conversion settlement			$ 13,128	(13,128)
Common stock issued for conversion settlement (in Shares)			131,282,467
Issuance of Series Y Preferred stock through a private placement		2,657,200
Issuance of Series Z Preferred stock through a private placement		250,000
Exchange of Series F Preferred Stock for Series Q Preferred stock		200,000
Exchange of Series I Preferred Stock for Series W Preferred stock		210,000
Exchange of Series K Preferred Stock for Series W Preferred stock		85,000
Exchange of Series V Preferred Stock for Series Y Preferred stock
Loss on conversion of Preferred stock				245,985				245,985
Net Income (loss)							(4,842,023)	(4,842,023)
Balance at Jun. 30, 2022	$ 3,304	$ 12,177,450	$ 60,703	$ 77,986,132	$ 100,000	$ (132)	$ (103,017,946)	$ (24,867,939)
Balance (in Shares) at Jun. 30, 2022	33,038,213		607,030,697

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (loss)	$ (4,842,023)	$ (28,761,078)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization	21,242	23,131
Common and preferred stock issued for services	522,535	1,437,369
(Gain) Loss on net change in valuation of derivative liability	1,568,898	23,944,836
Debt discount recognized as interest expense	3,743	33,406
Net unrealized (gain)loss on fair value of securities	142,705	(40,400)
Loss on exchange of preferred stock		40,000
(Gain) Loss on conversion of preferred stock	245,985	1,119,284
Gain on write off of payable	(50,000)
Change in Assets (Increase) Decrease in:
Contracts receivable	761,676	13,880
Contract asset	(724,975)	(63,500)
Inventory asset	(15,175)	(2,850)
Prepaid expenses and other assets	1,496	44,769
Other receivable		1,200
Accounts payable	744,372	(258,796)
Accrued expenses	57,824	48,802
Contract liabilities	(288,949)	(39,435)
NET CASH USED IN OPERATING ACTIVITIES	(1,850,644)	(2,459,382)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(9,000)	(9,000)
NET CASH USED IN INVESTING ACTIVITIES	(9,000)	(9,000)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease	(4,544)	(4,544)
Repayment of loans, net		53,750
Repayment of loans, related party, net		(94,883)
Net payments on cumulative preferred stock dividends payable	15,135	91,800
Proceeds on convertible promissory notes		(15,228)
Payments on promissory notes
Net proceeds for issuance of preferred stock for cash - mezzanine classification	2,843,700	2,560,175
NET CASH PROVIDED BY FINANCING ACTIVITIES	2,854,291	2,591,070
NET INCREASE IN CASH	994,647	122,688
CASH BEGINNING OF PERIOD	706,421	416,121
CASH END OF PERIOD	1,701,068	538,809
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest and dividends paid	828,638	3,741
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt, plus accrued interest, and other fees	119,634	133,705
Issuance of Series T preferred shares in exchange for property		630,000
Issuance of Series O dividends	72	33
Preferred stock converted to common stock - mezzanine	1,407,842	3,010,409
Preferred stock converted to common stock - equity		5,455
Exchange from mezzanine to liability	495,000	2,804,167
Issuance of warrants deemed dividends		2,037,849
Fair value of derivative at issuance		$ 54,652
Common stock issued as settlement	$ 13,128

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	1. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of OriginClear, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2021. The Company has implemented a new outsourced water treatment business called Water On Demand (“WOD”), which it will conduct through its wholly owned subsidiary, Water on Demand, Inc. (“WODI”). The WOD model intends to offer private businesses water self-sustainability as a service. In addition to WODI, four subsidiaries have been established to house capital dedicated to this program. During the six months ended June 30, 2022, the Water On Demand business reached its first $1 million milestone in dedicated capital. The Company is evaluating the first pilot opportunity to enable a commercial customer to treat its dirty water by the gallon as a managed service, instead of the client having to come up with significant up-front capital. The Company has announced that it plans to spin off the WOD business into its newly formed wholly owned subsidiary, Water On Demand, Inc. Going Concern The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2021 expressed substantial doubt about our ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, achieving a level of profitable operations and receiving additional cash infusions. During the six months ended June 30, 2022, the Company obtained funds from the sales of its preferred stock. Management believes this funding will continue from its’ current investors and from new investors. For the six months ended June 30, 2022, the Company generated revenue of $4,402,072 and has standing purchase orders and open invoices with customers, which will provide funds for operations. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case of equity financing.

Summary of Significant Accounti

Summary of Significant Accounting Polices	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Net Earnings (Loss) per Share Calculations Basic loss per share calculation is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted earnings per share were not the same as the basic loss per share for the six months ended June 30, 2022 and 2021, as the inclusion of any potential shares in the six months ended June 30, 2022 and 2021, would have an anti-dilutive effect due to the Company generating a loss. For the Six Months 2022 2021 Income (Loss) to common shareholders (Numerator) $ (4,842,023 ) $ (30,798,927 ) Basic weighted average number of common shares outstanding (Denominator) 495,173,641 122,395,397 Diluted weighted average number of common shares outstanding (Denominator) 495,173,641 122,395,397 The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable shares if their impact is dilutive. Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs. Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients’ financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was $0 and $0 as of June 30, 2022 and December 31, 2021, respectively. The net contract receivable balance was $1,389,291 and $2,150,967 at June 30, 2022 and December 31, 2021, respectively. Prepaid Expenses The Company records expenditures that have been paid in advance as prepaid expenses. The prepaid expenses are initially recorded as assets, because they have future economic benefits, and are expensed at the time the benefits are realized. The prepaid expenses balance was $11,615 and $13,111 at June 30, 2022 and December 31, 2021, respectively. Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at June 30, 2022 and determined there was no impairment of indefinite lived intangibles and goodwill. Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years 6/30/2022 12/31/21 Machinery and Equipment $ 383,569 $ 383,569 Computer Equipment 62,854 62,854 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 603,373 603,373 Less accumulated depreciation (411,224 ) (389,982 ) Net Property and Equipment $ 192,149 $ 213,391 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that the facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the six months ended June 30, 2022 and 2021, was $21,242 and $23,131, respectively. Inventory The Company expenses inventory on a first in, first out basis, and had raw materials of $18,025 and $2,850 as of June 30, 2022 and December 31, 2021, respectively. Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants vest immediately and the total stock-based compensation charge is recorded in the period of the measurement date. Accounting for Derivatives The Company evaluates all its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not to recognized in the balance sheet, where it is practicable to estimate that value. As of June 30, 2022, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of June 30, 2022. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 67,813 $ 67,813 $ - $ - Total Assets measured at fair value $ 67,813 $ 67,813 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liabilities $ 8,095,027 $ - $ - $ 8,095,027 Total liabilities measured at fair value $ 8,095,027 $ - $ - $ 8,095,027 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2022 $ 6,526,129 Fair value at issuance - Loss on conversion of debt and change in derivative liability 1,568,898 Balance as of June 30, 2022 $ 8,095,027 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: June 30, 2022 Risk free interest rate 0.17% - 3.01 % Stock volatility factor 20.0% - 179.0 % Weighted average expected option life 6 months - 5 years Expected dividend yield None Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated. Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income. Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered. Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers. Recently Issued Accounting Pronouncements Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Capital Stock

Capital Stock	6 Months Ended
	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
CAPITAL STOCK	3. CAPITAL STOCK Preferred Stock Series C On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry in exchange for his continued employment with the Company. The holder of Series C preferred stock is not entitled to receive dividends, is not entitled to any liquidation preference and shares of Series C preferred stock does not have any conversion rights. The Series C Preferred Stock entitles the holder to 51% of the total voting power of our stockholders. The purchase price of the Series C preferred stock was $0.0001 per share representing a total purchase price of $0.10 for 1,000 shares. As of June 30, 2022, there were 1,000 shares of Series C preferred stock outstanding held by Mr. Eckelberry. Series D-1 On April 13, 2018, the Company designated 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock are not entitled to dividends and do not have a liquidation preference. Each share of Series D-1 preferred stock is convertible into 0.0005 of one share of common stock. The Series D-1 preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock, which amount may be increased to 9.99% at the holders discretion upon 61 days’ written notice. As of June 30, 2022, there were 31,500,000 shares of Series D-1 preferred stock issued and outstanding. Series E On August 14, 2018, the Company designated 4,000,000 shares of its authorized preferred stock as Series E preferred stock. The shares of Series E preferred stock are not entitled to dividends and not have a liquidation preference. Each share of Series E preferred stock is convertible into 0.05 shares of common stock. The shares of Series E preferred stock do not carry any voting rights. The Series E preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock which amount may be increased to 9.99% at the holder’s discretion. As of June 30, 2022, there were 1,537,213 shares of Series E preferred stock issued and outstanding. Series F On August 14, 2018, the Company designated 6,000 shares as Series F preferred stock. The shares of Series F preferred stock have a liquidation preference equal to the stated value of $1,000 per share plus any accrued but unpaid dividends. The Series F preferred stock is not convertible into common stock. The holders of outstanding shares of Series F preferred stock are entitled to quarterly dividends at the annual rate of 8% of the stated value, in preference to any dividends on the common stock. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company was required to redeem all outstanding shares of Series F preferred stock on September 1, 2020. As of December 31, 2021, there were 260 shares of Series F preferred stock issued and outstanding. As of December 31, 2021, a holder of 100 of such outstanding shares of Series F preferred stock, agreed that the Company would have no obligation to redeem such holder’s shares of Series F preferred stock prior to September 1, 2022. On February 14, 2022, the Company exchanged those 100 shares of the holder’s Series F preferred stock for 100 shares of Series Q preferred stock. During the six months ended June 30, 2022, the Company exchanged an additional 100 shares of Series F preferred stock for 100 shares of Series Q preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of June 30, 2022, the Company had 60 outstanding shares of Series F preferred stock, which the Company was required to, and failed to redeem on September 1, 2020, and was and remains in default for an aggregate redemption price (equal to the stated value) of $60,000. Series G On January 16, 2019, the Company designated 6,000 shares as Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. The Series G preferred stock does not have voting rights, except as required by law and is not convertible into common stock. The Company may, in its sole discretion, at any time while the Series G preferred stock is outstanding, redeem all or any portion of the outstanding Series G preferred stock at a price equal to the stated value plus any accrued but unpaid dividends. The Company was required to redeem such shares of Series G preferred stock on April 30, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser received shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. As of June 30, 2022, there were 25 shares of Series G preferred stock issued and outstanding, which the Company was required to, and failed to redeem on April 30, 2021, and was and remains in default for an aggregate redemption price (equal to the stated value) of $25,000. Series I On April 3, 2019, the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I is not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock. The Company has the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series I between May 2, 2021 and June 10, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the six months ended June 30, 2022, the Company exchanged an aggregate of 210 shares of Series I preferred stock for 210 shares of Series W preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of June 30, 2022, there were 25 shares of Series I preferred stock issued and outstanding which the Company was required to, and failed to redeem between on June 10, 2021, and was and remains in default for an aggregate redemption price (equal to the stated value) of $25,000. Series J On April 3, 2019, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain make-good shares for certain prior investors. During the six months ended June 30, 2022, the Company issued an aggregate of 512,737 shares of common stock upon conversion of 5 shares of Series J preferred stock, for a loss in the amount of $5,203. As of June 30, 2022, there were 210 shares of Series J preferred stock issued and outstanding. Series K On June 3, 2019, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K is not entitled to any voting rights except as may be required by applicable law, and is not convertible into common stock. The Company has the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company is required to redeem such shares of Series K between August 5, 2021 and April 24, 2022, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the six months ended June 30, 2022, the Company exchanged an aggregate of 85 shares of Series K preferred stock for 85 shares of Series W preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. On January 18, 2022, the Company returned $63,500 to an investor, and redeemed 63.5 shares of Series K preferred stock. As of June 30, 2022, there were 432 shares of Series K preferred stock issued and outstanding which the Company was required to, and failed to redeem between August 5, 2021 and March 26, 2022, and was and remains in default for an aggregate redemption price (equal to the stated value) of $432,150. Series L On June 3, 2019, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series L COD, which includes certain make-good shares for certain prior investors. During the six months ended June 30, 2022, the Company issued an aggregate of 15,973,192 shares of common stock upon conversion of 134 shares of Series L preferred stock, for a loss in the amount of $240,782. As of June 30, 2022, there were 476 shares of Series L preferred stock issued and outstanding. Series M On July 1, 2020, the Company designated 800,000 shares of its preferred stock as Series M. Each share of Series M has a stated value of $25. The Series M is not convertible into common stock. The holders of outstanding shares of Series M are entitled to receive dividends, at the annual rate of 10%, payable monthly, payable in preference and priority to any payment of any dividend on the common stock. The Series M is entitled to a liquidation preference in an amount equal to $25 per share plus any declared but unpaid dividends, before any payments to holders of common stock. The Series M have no pre-emptive or subscription rights, and there are no sinking fund provisions applicable to the Series M. The Series M does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the Certificate of Designation of Series M preferred stock. To the extent it may lawfully do so, the Company may, in its sole discretion, at any time when there are outstanding shares of Series M, redeem any or all of the then outstanding shares of Series M at a redemption price of $37.50 per share (150% of the stated value) plus any accrued but unpaid dividends. As of June 30, 2022, there were 40,300 shares of Series M preferred stock issued and outstanding. Series O On April 27, 2020, the Company designated 2,000 shares of preferred stock as Series O. The Series O has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series O has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series O. The Series O does not have voting rights except as required by law. The Series O is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series O being converted by the conversion price, provided that, the Series O may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series O at any time while the Series O are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the six months ended June 30, 2022, the Company issued an aggregate of 720,665 shares of common stock in prorated 4% annualized dividends which are recorded as interest expense. As of June 30, 2022, there were 615 shares of Series O preferred stock issued and outstanding. Series P On April 27, 2020, the Company designated 500 shares of preferred stock as Series P. The Series P has a stated value of $1,000 per share, and entitles holders to receive dividends on an as-converted basis with the Company’s common stock. The Series P is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Certificate of Designation of Series P preferred stock, which includes certain make-good shares for certain prior investors, and provided that, the Series P may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Series P entitles the holders to a payment on an as-converted and pari passu basis with the common stock upon any liquidation. The Series P has no preemptive or subscription rights, and there is no sinking fund or redemption provisions applicable to the Series P. The Series P votes on an as-converted basis with the common stock, subject to the beneficial ownership limitation. As of June 30, 2022, there were 57.5 shares of Series P preferred stock issued and outstanding. Series Q On August 21, 2020, the Company designated 2,000 shares of preferred stock as Series Q. The Series Q has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series Q has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series Q has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series Q. The Series Q does not have voting rights except as required by law. The Series Q is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series Q being converted by the conversion price, provided that, the Series Q may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series Q at any time while the Series Q are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the six months ended June 30, 2022, the Company exchanged 200 shares of Series F preferred stock for 200 shares of Series Q preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of June 30, 2022, there were 715 shares of Series Q preferred stock issued and outstanding. Series R On November 16, 2020, the Company designated 5,000 shares of preferred stock as Series R. The Series R has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 10% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series R holders are not entitled to any voting rights except as may be required by applicable law. The Series R is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series R being converted by the conversion price; certain prior investors are also entitled to certain make-good shares; provided that, the Series R may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series R at any time while the Series R are outstanding at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid cash dividends, or, if paid in shares of common stock, in an amount of shares determined by dividing the stated value being redeemed by the conversion price. The subscribers were offered warrants with the purchase of Series R. During the six months ended June 30, 2022, the Company issued an aggregate of 28,625,607 shares of common stock upon conversion of 398 shares of Series R preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of June 30, 2022, there were 3,034 shares of Series R preferred stock, and the Company issued 101,498,340 Series A warrants (with an exercise price of $0.05) and 49,177,670 Series B warrants (with an exercise price of $0.10) along with the Series R preferred stock, however, all warrants issued expired as of June 30, 2022. Series S On February 5, 2021, the Company designated 430 shares of preferred stock as Series S. The Series S has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series S holders are not entitled to any voting rights except as may be required by applicable law. The Series S is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series S being converted by the conversion price, provided that, the Series S may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series S at any time while the Series S are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. As of June 30, 2022, there were 170 shares of Series S preferred stock issued and outstanding. Series T On February 24, 2021, the Company designated 630 shares of preferred stock as Series T. The Series T has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 10% of the stated value, payable monthly. The Series T holders are not entitled to any voting rights except as may be required by applicable law. The Series T is convertible into common stock of the Company pursuant to the Series T COD, provided that, the Series T may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company will have the right (but no obligation) to redeem the Series T at any time while the Series T are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. On March 1, 2021, the Company issued an aggregate of 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per terms of a Securities Purchase Agreement (the “SPA”). Per the SPA, the Company agreed to sell to Purchaser, and Purchaser agreed to purchase from the Company, 630 shares of the Company’s Series T, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share per terms of the SPA, which may be exercised at any time in whole or in part. Per the SPA, the Series T, including any convertible shares acquired pursuant to exercise of the warrants, the Company shall pay 10% annual dividends in cash, paid monthly. Purchaser may convert any portion of the Series T, including convertible shares acquired pursuant to exercise of the warrants, at any time into shares of the Company’s common stock at an agreed upon conversion rate per terms of the SPA. The purchaser and the Company agreed that in lieu of the purchase price for the Series T, the Purchaser transferred to the Company real property, with an aggregate value agreed to be $630,000 based on an appraisal from an international independent company. The real property consists of residential real estate in Buenos Aires Argentina valued at $580,000, and eight undeveloped lots valued at $50,000 in Terralta private neighborhood development. The real property exchanged for 630 shares of Series T was recorded at $630,000 and reflected on the balance sheet as a long term asset for sale. The fair value of the warrants associated with acquiring 25,200,000 preferred shares were valued at $2,037,849, using the Black Scholes model and accounted for as deemed dividends and reflected in stockholder’s equity as accumulated paid in capital. The Company has actively listed the residential real property for sale since July 2021. On September 13, 2021, the Company received an offer for the property for $464,000, which was $116,000 below the original independent appraisal of $580,000. Based on that indicator of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the long term asset for sale from $630,000 to $514,000 on the balance sheet and recorded an impairment of $116,000 in the consolidated financial statements. During the six months ended June 30, 2022, the Company issued an aggregate of 53,327,672 shares of common stock upon conversion of 344 shares of Series T preferred stock. As of June 30, 2022, there were 286 shares of Series T preferred stock issued and outstanding. Series U On May 26, 2021, the Company designated 5,000 shares of preferred stock as Series U. The Series U has a stated value of $1,000 per share. The Series U holders are not entitled to any dividends and do not have any voting rights except as may be required by applicable law. The Series U is convertible into common stock of the Company in an amount determined by dividing 150% of the stated value of the Series U being converted by the conversion price; certain prior investors are also entitled to certain make-good shares; provided that, the Series U may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the lesser of $0.20 or the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series U at any time at a redemption price equal to, if paid in cash, the stated value, or, if paid in shares of common stock, in an amount of shares determined by dividing 200% of the stated value being redeemed by the conversion price then in effect, and adding any applicable make-good shares. During the six months ended June 30, 2022, the Company issued an aggregate of 22,794,493 shares of common stock upon conversion of 432 shares of Series U preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of June 30, 2022, there were 635 shares of Series U preferred stock issued and outstanding, along with 18,115,000 Series A warrants (with an exercise price of $0.05), 6,246,000 Series B warrants (with an exercise price of $0.10), and 1,561,000 Series C warrants (with an exercise price of $1.00) issued and outstanding with a fair value of $19,944 on the original issuance. The warrants were valued using the Black Scholes model (See Note 4). Series V On December 1, 2021, the Company filed a certificate of withdrawal of the Company’s certificate of designation of Series V preferred stock and filed a certificate of designation for a new series of Series V preferred stock with the Secretary of State of Nevada. Pursuant to the Series V COD, the Company designated 3,000 shares of preferred stock as Series V. The Series V has an original issue price of $100,000 per share, and holders are entitled to an annual distribution of 25% of annual net profits of newly established Company wholly-owned, Water On Demand subsidiaries, designated by each holder, paid within 3 months of subsidiary’s accounting year-end. The Series V holders are not entitled to any dividends and do not have any voting rights except as may be required by applicable law. The Series V is convertible into common stock of the Company pursuant to the Series V COD, provided that, the Series V may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company has the right (but no obligation) to redeem the Series V at any time at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid distributions of 25% of subsidiary’s annual net profits. During the six months ended June 30, 2022, the Company exchanged 4 shares of Series V preferred stock for 4 shares of Series Y preferred stock, and exchanged an aggregate of 3,200,000 warrants associated with the Series V into Series Y. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of June 30, 2022, there were no shares of Series V preferred stock issued and outstanding. Series W On April 28, 2021, the Company designated 3,390 shares of preferred stock as Series W. The Series W has a stated value of $1,000 per share, and Series W holders are entitled to cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly. The Series W holders are not entitled to any voting rights except as may be required by applicable law. The Series W is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series W being converted by the conversion price; provided that, the Series W may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock. The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series W at any time at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the six months ended June 30, 2022, the Company issued 85 shares of Series W preferred stock in exchange for 85 shares of Series K preferred stock, issued 210 shares of Series W preferred stock in exchange for 210 shares of Series I preferred stock and issued an aggregate of 3,811,810 shares of common stock upon conversion of 45 shares of Series W preferred stock. The shares were issued within the terms of the agreement and no gain or loss was recognized. As of June 30, 2022, there were 995 shares of Series W preferred stock issued and outstanding. Series X On August 10, 2021, the Company designated 25 shares of preferred stock as Series X. The Series X has a stated value of $10,000 per share. The Series X holders are not entitled to any dividends and do not have any voting rights except as may be required by applicable law. The Series X is convertible into common stock of the Company pursuant to the Series X COD, provided that, the Series X may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which amount may be increased up to 9.99% upon 61 days’ written notice). Beginning on the one year anniversary of the subscription agreement for the Series X Preferred Stock, until the two year anniversary of the subscription agreement, the holders will have the right to require the Company to redeem all of the Series X purchased by the subscriber at a price equal to 125% of the $250,000 original purchase price, or $312,500. The holders also have the right, exercisable at any time, to require the Company to redeem all of the holder’s Series X in exchange for the issuance of shares of the Company’s common stock in an amount equal to 250% of the original $250,000 purchase price, or $625,000, divided by the closing price of the Company’s common stock as of the date the holders executed the subscription agreement. On August 10, 2021, the Company issued and sold to an accredited investor an aggregate of 25 shares of Series X preferred stock for a purchase price of $250,000. Per the Series X COD, as of March 31, 2022, $140,000 of the $250,000 was classified as restricted cash. As of June 30, 2022, there were 25 shares of Series X preferred stock issued and outstanding. Series Y On December 6, 2021, the Company designated 3,000 shares of preferred stock as Series Y. The Series Y has an original issue price of $100,000 per share, and holders are entitled to receive, on a pro rata and pari passu basis, annual distribution of 25% of annual net profits of newly established, wholly-owned, Water On Demand subsidiaries, designated by each holder, paid within 3 months of subsidiary’s accounting year-end. The Series Y holders are not entitled to any voting rights except as may be required by applicable law. The Series Y is convertible into common stock of the Company pursuant to the Series Y COD, provided that, the Series Y may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company has the right (but no obligation) to redeem the Series Y at any time at a redemption

Restricted Stock and Warrants

Restricted Stock and Warrants	6 Months Ended
	Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]
RESTRICTED STOCK AND WARRANTS	4. RESTRICTED STOCK AND WARRANTS Restricted Stock to CEO Between May 12, 2016, and January 1, 2022, the Company entered into Restricted Stock Grant Agreements (“the RSGAs”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGAs are performance based shares. The RSGAs provides for the issuance of up to an aggregate of 242,109,214 shares of the Company’s common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 121,054,607 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization Restricted Stock to the Board, Employees and Consultants Between May 12, 2016, and April 1, 2022, the Company entered into Restricted Stock Grant Agreements (“the BEC RSGAs”) with its members of the Board, employees, and consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the BEC RSGAs are performance based shares. The BEC RSGAs provide for the issuance of up to 367,141,542 shares of the Company’s common stock to employees and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 183,570,771 shares of its common stock; b) If the Company’s consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 14, 2019, the Board of Directors approved an amendment to the RSGAs and BEC RSGAs to include an alternative vesting schedule for the Grantees and on January 26, 2022, the Company amended the procedures for processing the RSGAs and BEC RSGAs. Once a Grantee is eligible to participate in alternate vesting, then they will be added to the list of alternate vestees, enlarging the pool of vestees among which, 10% of stock sales that are allowed under the agreement is divided for the next year. The Company then (i) calculates the value of the Company common stock traded in the year immediately prior to the vesting year, using daily adjusted close and volume, as quoted on the public securities trading market on which the Company’s common stock is then traded (ii) determines the cost basis of the shares, which shall be the closing price quoted on the public securities trading market, quoted on the first trading day of the vesting year which will be the grantee’s cost basis, and (iii) applies the 10% calculation and divides it into the number of qualifying alternate vestees, giving the gross number of shares available to each Grantee. For each alternate vestee for each year in which there occurs a vesting or a potential vesting, the Company (i) does a 90-day lookback from the first day of the latest vesting month, to limit cumulative vesting of shares for each alternate vestee for the 90-day period to 1% of total Company shares of common stock outstanding for the period, using the then current figure for shares outstanding at the time of the lookback; (ii) places the excess shares (the “Overlimit Shares”) in suspense for issuance in the next 90-day period so that in each future 90-day period they may be issued, and (iii) if on the 90-day lookback, cumulative issuances are less than 1% of shares outstanding, the Company will add the shares from previous 90-day lookback, if any. For the avoidance of doubt, the Company will not record any Overlimit Shares as vested until such as time as they have been finally issued. If the fair market value of the Company’s common stock on the date the shares are vested is less than the fair market value of the Company’s common stock on the effective date of the RSGA or BEC RSGA, then the number of vested shares issuable (assuming all conditions are satisfied) shall be increased so that the aggregate fair market value of vested shares issuable on the vesting date equals the aggregate fair market value that such number of shares would have had on the effective date. Upon the occurrence of a Company performance goal, the right to participate in the alternate vesting schedule will terminate, and the vesting of the remaining unvested shares will be as set forth under the restricted stock award agreement. During the six months ended June 30, 2022, the Company did not issue any shares relating to the RSGAs nor the BEC RSGAs. Warrants During the six months ended June 30, 2022, the Company granted 24,457,600 common stock purchase warrants, associated with the issuance of preferred stock. A summary of the Company’s warrant activity and related information follows for the six months ended June 30, 2022: June 30, 2022 Number of Weighted Outstanding - beginning of period 217,085,783 $ 0.0868 Granted 24,457,600 $ 0.1250 Exercised - - Expired (151,176,010 ) $ 0.0662 Outstanding - end of period 90,667,373 $ 0.1173 At June 30, 2022, the weighted average remaining contractual life of warrants outstanding: June 30, 2022 Weighted Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.02 600,000 600,000 4.18 $ 0.05 25,200,000 25,200,000 0.67 $ 0.10 20,115,000 20,115,000 0.02 - 1.65 $ 0.25 10,006,000 10,006,000 1.25 – 4.50 $ 0.0275 8,727,273 8,727,273 8.92 $ 0.125 24,457,600 24,457,600 4.52 – 6.00 $ 1.00 1,561,500 1,561,500 2.00 - 2.47 90,667,373 90,667,373 At June 30, 2022, the aggregate intrinsic value of the warrants outstanding was $0.

Convertible Promissory Notes

Convertible Promissory Notes	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
CONVERTIBLE PROMISSORY NOTES	5. CONVERTIBLE PROMISSORY NOTES As of June 30, 2022, the outstanding convertible promissory notes are summarized as follows: Convertible Promissory Notes $ 3,012,155 Less current portion 878,283 Total long-term liabilities $ 2,133,872 Maturities of long-term debt for the next three years are as follows: Year Ending June 30, Amount 2023 878,283 2024 2,120,100 2025 13,772 $ 3,012,155 On various dates from November 2014 through April 2015, the Company issued unsecured convertible promissory notes (the “2014-2015 Notes”), that matured on various dates and were extended for an additional sixty (60) months from the effective date of each Note. The 2014-2015 Notes bear interest at 10% per year. The maturity dates were extended to November 2023 through April 2024. The 2014-2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes. In addition, for as long as the 2014-2015 Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the 2014-2015 Notes or such other convertible notes or a term was not similarly provided to the purchaser of the 2014-2015 Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the 2014-2015 Notes and such other convertible notes. The conversion feature of the 2014-2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2014-2015 Notes. During the six months ended June 30, 2022, the Company issued 12,461,909 shares of common stock, upon conversion of $69,900 in principal, plus accrued interest of $49,734. As of June 30, 2022, the 2014-2015 Notes had an aggregate remaining balance of $860,100, which are long term. The unsecured convertible promissory notes (the “OID Notes”) had an aggregate remaining balance of $184,124, plus accrued interest of $13,334. The OID Notes included an original issue discount and one-time interest, which has been fully amortized. The OID Notes matured on December 31, 2017, which were extended to June 30, 2023. The OID Notes were convertible into shares of the Company’s common stock at a conversion price initially of $30,620. After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the OID Notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the OID Notes. As of June 30, 2022, the remaining balance on the OID Notes was $62,275, which is short term. The Company issued various, unsecured convertible promissory notes (the “2015 Notes”), on various dates with the last of the 2015 Notes being issued in August 2015. The 2015 Notes matured and were extended from the date of each tranche through maturity dates ending on February 2024 through March 2024, and April 2024 through August 2024. The 2015 Notes bear interest at 10% per year. The 2015 Notes are convertible into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015 Notes. The conversion feature of the 2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015 Notes. As of June 30, 2022, the 2015 Notes had an aggregate remaining balance of $1,200,000, of which $1,200,000 is long term. The Company issued a convertible note (the “Dec 2015 Note”) in exchange for accounts payable in the amount of $432,048, which could be converted into shares of the Company’s common stock after December 31, 2015. The Dec 2015 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Dec 2015 Note did not meet the criteria of a derivative, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Dec 2015 Note and recognized as interest expense in the financial statements. On January 1, 2016, the Dec 2015 Note met the criteria of a derivative and was accounted for under ASC 815. The Dec 2015 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of June 30, 2022, the remaining balance on the Dec 2015 Note was $167,048, which is short term. The Company issued a convertible note (the “Sep 2016 Note”) in exchange for accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. The Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Sep 2016 Note met the criteria of a derivative and was accounted for under ASC 815. The Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The Sep 2016 Note did not meet the criteria of a derivative at the date of the issuance, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. As of June 30, 2022, the remaining balance on the Sep 2016 Note was $430,896, which is short term. The Company issued two (2) unsecured convertible promissory notes (the “Apr & May 2018 Notes”), in the aggregate amount of $300,000 on April 2, 2018 and May 31, 2018. The Apr & May 2018 Notes had maturity dates of April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per year. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty-five (25) trading days prior to conversion. The conversion feature of the Apr & May 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. On March 13, 2019, the Company entered into a settlement agreement with the investor in the amount of $570,000, based on the outstanding balance due and payable under the Apr & May 2018 Notes. The Company set up a reserve of 2,630,769 shares of common stock of the Company for issuance upon conversion by the investor of the amounts owed under the Notes, in accordance with the terms of the Notes, including, but not limited to the beneficial ownership limitations contained in the Notes. In addition to the foregoing, upon the sale by the investor of the settlement shares as delivered to the investor by the Company, resulting in total net proceeds less than the settlement value, the investor is entitled to additional settlement shares of the Company’s common stock. If after the investor has sold all settlement shares, the investor delivers a written notice to the Company certifying that the investor is entitled to additional settlement shares of the Company’s common stock (the “Make-Whole Shares”). The number of make-whole shares being equal to the greater of ((i) zero and (ii) the quotient of (1) the difference of (x) the settlement value with respect to each sale of shares by the Investor after the delivery of the Settlement Shares, minus (y) the aggregate net consideration received by the Investor from the resale of all shares of common stock issued by the Company, divided by (2) the average trailing closing price for ten (10) trading days for the shares immediately preceding the date of delivery of the make-whole shares. As of June 30, 2022, the remaining balance on the May 2018 Note was $218,064, which is short term. The Company entered into an unsecured convertible promissory note (the “Nov 20 Note”), on November 19, 2020 in the amount of $50,000. The Company received funds in the amount of $50,000. The Nov 20 Note had an original maturity date of November 19, 2021 and was extended for an additional sixty (60) months from the maturity date. The Nov 20 Note bears interest at 10% per year. The Nov 20 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Nov 20 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. As of June 30, 2022, the remaining balance on the Nov 20 Note was $13,772, which is long term. The Company entered into an unsecured convertible promissory note (the “Jan 21 Note”), on January 25, 2021 in the amount of $60,000. The Company received funds in the amount of $60,000. The Jan 21 Note had an original maturity date of January 25, 2022 and was extended for an additional sixty (60) months from the maturity date. The Jan 21 Note bears interest at 10% per year. The Jan 21 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower of (a) $0.05 per share, (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Jan 25 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $3,743 during the six months ended June 30, 2022. As of June 30, 2022, the balance of the Jan 21 Note was $60,000, which is long term. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable, so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations. The derivative liability recognized in the financial statements as of June 30, 2022 was $8,095,027.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	6 Months Ended
	Jun. 30, 2022
Revenue from Contracts with Customers [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	6. REVENUE FROM CONTRACTS WITH CUSTOMERS Equipment Contracts Revenues and related costs on equipment contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. The following table represents a disaggregation of revenue by type of good or service from contracts with customers for the June 30, 2022 and 2021. Six Months Ended June 30, 2022 2021 Equipment Contracts $ 3,383,906 $ 1,181,981 Component Sales 677,963 500,234 Waste Water Treatment Systems 301,770 - Rental Income 13,146 14,687 Services Sales 25,287 30,698 $ 4,402,072 $ 1,727,600 Revenue recognition for other sales arrangements, such as sales for components, and service sales will remain materially consistent. Contract assets represents revenues recognized in excess of amounts billed on contracts in progress. Contract liabilities represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The contract asset for the six months ended June 30, 2022 and the year ended December 31, 2021, was $1,103,907 and $378,932, respectively. The contract liability for the six months ended June 30, 2022, and the year ended December 31, 2021, was $1,597,997 and $1,886,946, respectively.

Financial Assets

Financial Assets	6 Months Ended
	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
FINANCIAL ASSETS	7. FINANCIAL ASSETS Fair value investment in Securities On November 12, 2021, the Company served a conversion notice to WTII and recorded additional interest and fees of $15,988 through that date, according to the terms of the securities purchase agreement for an aggregate of $149,867. The Note was converted into 45,208,649 shares of WTII common stock. As of June 30, 2022, the investment in securities was recorded at fair value in the amount of $67,813, with an unrealized loss of $131,105. On May 15, 2018, the Company received 4,000 shares of Water Technologies International, Inc. (“WTII”) Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into one thousand (1,000) shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the financial statements as of June 30, 2018. As of June 30, 2022, the fair value of the preferred shares was $6,000.

Loans Payable

Loans Payable	6 Months Ended
	Jun. 30, 2022
Loans Payable Disclosure [Abstract]
LOANS PAYABLE	8. LOANS PAYABLE Secured Loans Payable The Company entered into short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. As of December 31, 2020, the finance cost was fully amortized. During the year ended December 31, 2021, the Company settled the majority of the loans in the amount of $262,250, of which $157,250 was recognized on the statement of operations as a gain on write-off of loan payable. The term of the loans ranged from two months to six months. During the period ended June 30, 2022, the Company received $25,000 as a settlement and wrote off $50,000 of secured loans payable. The net balance as of June 30, 2022 was $30,646. Small Business Administration Loans Between April 30, 2020 and September 12, 2020, the Company received total loan proceeds in the amount of $505,000, which included an aggregate of $345,000 under the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief and Economic Security Act, an Economic Injury Disaster Loan (the “EIDL”) in the amount of $150,000, and an Economic Injury Disaster Grant in the amount of $10,000. The principal and accrued interest under the PPP was forgivable if the Company used the PPP loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and otherwise complied with PPP requirements. The Company used the full proceeds of the PPP loan specifically for eligible purposes per requirements of the PPP and during the period ending December 31, 2021, the Company submitted satisfactory documentation regarding its compliance with the applicable requirements and obtained forgiveness of the PPP loan. The Company must repay any unforgiven principal amount, with interest, on a monthly basis following the deferral period for the EIDL. For the period ended December 31, 2021, the aggregate amount of $345,000 received under the PPP, and the Economic Injury Disaster Grant in the amount of $10,000 was recognized in the statement of operations as other income due to forgiveness.

Capital Leases

Capital Leases	6 Months Ended
	Jun. 30, 2022
Capital Leases [Abstract]
CAPITAL LEASES	9. CAPITAL LEASES The Company entered into a capital lease for the purchase of equipment during the year ended December 31, 2018. The lease is for a sixty (60) month term, with monthly payments of $757 per month, and a purchase option at the end of the lease for $1.00. As of June 30, 2022, there remain a current balance of $3,441.

Foreign Subsidiary

Foreign Subsidiary	6 Months Ended
	Jun. 30, 2022
Foreign Subsidiary [Abstract]
FOREIGN SUBSIDIARY	10. FOREIGN SUBSIDIARY On January 22, 2020 the Company entered into a strategic partnership with Permionics Separations Solutions, Inc., a unit of India’s Permionics Group (“Permionics”) for the Asia-Pacific Region. This strategic partnership assists the Company with overcoming the typical hurdles in commercializing a technology overseas with engineering support, developing customer proposals, infrastructure to handle logistics and purchasing, inventory and shipping from and into foreign countries, customer training, startup assistance and service. The Company believes that Permionics is best suited to accomplish all of the above for its customers in the Asia-Pacific countries and as a result, has terminated all activities of its fully owned subsidiary, OriginClear Technologies Limited, in Hong Kong, China, working instead with Permionics when applicable.

Assets Held For Sale

Assets Held For Sale	6 Months Ended
	Jun. 30, 2022
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
ASSETS HELD FOR SALE	11. ASSETS HELD FOR SALE The Company acquired real estate assets to be held for sale to finance their water projects, by issuing 630 shares of Series T preferred stock for a fair value of $630,000, in conjunction with common stock purchase warrants, through an asset purchase agreement. The assets held for sale consisted of residential property, plus eight (8) lots of undeveloped land. The real property has been listed actively on the market to be sold. Based on the offers received and the market conditions, the Company adjusted the fair value by $116,000 leaving a fair value of $514,000.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	12. COMMITMENTS AND CONTINGENCIES Facility Rental – Related Party Our Dallas based subsidiary, PWT, rents an approximately 12,000 square foot facility located at 2535 E. University Drive, McKinney, TX 75069, with a current monthly rent of $7,900. Warranty Reserve Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000 for the six months ended June 30, 2022. Litigation On March 12, 2021, OriginClear, Inc. Progressive Water Treatment, Inc. and T. Riggs Eckelberry, individually (collectively, the “C6 Plaintiffs”), and C6 Capital LLC (“C6 Capital”) agreed to settle the dispute between the parties relating to a merchant cash advance agreement entered into on July 17, 2018. Pursuant to the terms of the settlement, (i) C6 has vacated the judgment obtained by C6 Capital against the C6 Plaintiffs; (ii) C6 has released any and all bank levies, liens, security interests, powers of attorney, and other encumbrances its has against the C6 Plaintiffs; (iii) the C6 Plaintiffs have dismissed the plenary action commenced in the Supreme Court for the State of New York in and for the County of Broome against C6 Capital with prejudice and; (iv) the sister-state judgment C6 Capital obtained against the C6 Plaintiffs in California is currently in the process of being vacated by stipulation. Accordingly, the C6 Plaintiffs no longer owe any further amounts to C6 Capital with respect to the C6 Agreement. On February 12, 2019, Auctus Fund, LLC (“Auctus”) filed a complaint against OriginClear in the United States District Court for the District of Massachusetts for numerous claims arising from two convertible promissory notes and accompanying securities purchase agreements. On March 13, 2019, Auctus and OriginClear entered into a Settlement Agreement and Mutual General Release, under which Auctus would be permitted to convert $570,000 into OriginClear securities pursuant to the terms set forth in the convertible promissory notes. On February 2, 2021, OriginClear filed a Motion to Set Aside the Settlement Agreement as Void under Section 29(b) of the Securities Exchange Act of 1934 (the “Act”) for Auctus’ violation of Section 15(a) of the Act. If granted, the Settlement Agreement would be declared void and unenforceable. As of the filing date, no decision has been rendered on OriginClear’s Motion to Set Aside the Settlement Agreement.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	13. SUBSEQUENT EVENTS On July 5, 2022, the Company entered into settlement agreements with certain accredited investors pursuant to which the Company issued an aggregate of 45,642,386 shares of the Company’s common stock in settlement of certain claims with such persons. Between July 6, 2022 and August 12, 2022, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 5.4 shares of the Company’s Series Y preferred stock for an aggregate purchase price of $540,000. The Company also issued an aggregate of 4,320,000 warrants to these investors. On July 8, 2022, holders of the Company’s Series E preferred stock converted an aggregate of 1,537,213 Series E shares into an aggregate of 76,865 shares of the Company’s common stock. Between July 13, 2022 and August 5, 2022, holders of the Company’s Series Y preferred stock converted an aggregate of 8.8 Series Y shares into an aggregate of 70,931,416 shares of the Company’s common stock. On July 20, 2022, holders of the Company’s Series Q preferred stock converted an aggregate of 100 Series Q shares into an aggregate of 12,642,226 shares of the Company’s common stock. On July 20, 2022, holders of the Company’s Series W preferred stock converted an aggregate of 100 Series W shares into an aggregate of 12,642,226 shares of the Company’s common stock. Between July 21, 2022 and August 10, 2022, the Company issued to consultants an aggregate of 3,165,009 shares of the Company’s common stock for services. On July 26, 2022, per a settlement agreement, a prior holder of the Company’s common stock returned to the Company an aggregate of 409,518 shares of the Company’s common stock. On July 29, 2022, holders of convertible promissory notes converted an aggregate principal and interest amount of $150,912 into an aggregate of 27,438,605 shares of the Company’s common stock. On August 1, 2022, holders of the Company’s Series R preferred stock converted an aggregate of 1 Series R shares into an aggregate of 106,496 shares of the Company’s common stock. On August 5, 2022, holders of the Company’s Series T preferred stock converted an aggregate of 268 Series T shares into an aggregate of 29,777,778 shares of the Company’s common stock. On August 8, 2022, per electing and qualifying for the Restricted Stock Grant Agreement alternate vesting schedule, the Company issued to Mr. T. Riggs Eckelberry and one consultant an aggregate of 1,023,192 shares of the Company’s common stock. On August 8, 2022, holders of the Company’s Series U preferred stock converted an aggregate of 25 Series U shares into an aggregate of 3,028,099 shares, including make-good shares, of the Company’s common stock. On August 12, 2022, the Board of Directors for the Company’s wholly owned subsidiary, Water On Demand, Inc. (“WODI”), approved an equity incentive plan and form of Restricted Stock Grant Agreement for the issuance of shares in WODI to certain officers, directors, employees and consultants of WODI.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities.
Cash and Cash Equivalent	Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Net Earnings (Loss) per Share Calculations	Net Earnings (Loss) per Share Calculations Basic loss per share calculation is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted earnings per share were not the same as the basic loss per share for the six months ended June 30, 2022 and 2021, as the inclusion of any potential shares in the six months ended June 30, 2022 and 2021, would have an anti-dilutive effect due to the Company generating a loss. For the Six Months 2022 2021 Income (Loss) to common shareholders (Numerator) $ (4,842,023 ) $ (30,798,927 ) Basic weighted average number of common shares outstanding (Denominator) 495,173,641 122,395,397 Diluted weighted average number of common shares outstanding (Denominator) 495,173,641 122,395,397 The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable shares if their impact is dilutive.
Revenue Recognition	Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.
Contract Receivable	Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients’ financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was $0 and $0 as of June 30, 2022 and December 31, 2021, respectively. The net contract receivable balance was $1,389,291 and $2,150,967 at June 30, 2022 and December 31, 2021, respectively.
Prepaid Expenses	Prepaid Expenses The Company records expenditures that have been paid in advance as prepaid expenses. The prepaid expenses are initially recorded as assets, because they have future economic benefits, and are expensed at the time the benefits are realized. The prepaid expenses balance was $11,615 and $13,111 at June 30, 2022 and December 31, 2021, respectively.
Indefinite Lived Intangibles and Goodwill Assets	Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at June 30, 2022 and determined there was no impairment of indefinite lived intangibles and goodwill.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years 6/30/2022 12/31/21 Machinery and Equipment $ 383,569 $ 383,569 Computer Equipment 62,854 62,854 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 603,373 603,373 Less accumulated depreciation (411,224 ) (389,982 ) Net Property and Equipment $ 192,149 $ 213,391 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that the facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the six months ended June 30, 2022 and 2021, was $21,242 and $23,131, respectively.
Inventory	Inventory The Company expenses inventory on a first in, first out basis, and had raw materials of $18,025 and $2,850 as of June 30, 2022 and December 31, 2021, respectively.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants vest immediately and the total stock-based compensation charge is recorded in the period of the measurement date.
Accounting for Derivatives	Accounting for Derivatives The Company evaluates all its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not to recognized in the balance sheet, where it is practicable to estimate that value. As of June 30, 2022, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of June 30, 2022. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 67,813 $ 67,813 $ - $ - Total Assets measured at fair value $ 67,813 $ 67,813 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liabilities $ 8,095,027 $ - $ - $ 8,095,027 Total liabilities measured at fair value $ 8,095,027 $ - $ - $ 8,095,027 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2022 $ 6,526,129 Fair value at issuance - Loss on conversion of debt and change in derivative liability 1,568,898 Balance as of June 30, 2022 $ 8,095,027 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: June 30, 2022 Risk free interest rate 0.17% - 3.01 % Stock volatility factor 20.0% - 179.0 % Weighted average expected option life 6 months - 5 years Expected dividend yield None
Segment Reporting	Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.
Marketable Securities	Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income.
Licensing agreement	Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered.
Work-in-Process	Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Polices (Tables)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Schedule of loss per share anti-dilutive effect	For the Six Months 2022 2021 Income (Loss) to common shareholders (Numerator) $ (4,842,023 ) $ (30,798,927 ) Basic weighted average number of common shares outstanding (Denominator) 495,173,641 122,395,397 Diluted weighted average number of common shares outstanding (Denominator) 495,173,641 122,395,397
Schedule of estimated useful life	Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years
Schedule of property plant and equipment	6/30/2022 12/31/21 Machinery and Equipment $ 383,569 $ 383,569 Computer Equipment 62,854 62,854 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 603,373 603,373 Less accumulated depreciation (411,224 ) (389,982 ) Net Property and Equipment $ 192,149 $ 213,391
Schedule of fair value of financial instruments	Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 67,813 $ 67,813 $ - $ - Total Assets measured at fair value $ 67,813 $ 67,813 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liabilities $ 8,095,027 $ - $ - $ 8,095,027 Total liabilities measured at fair value $ 8,095,027 $ - $ - $ 8,095,027
Schedule of reconciliation of the derivative liability for which level 3 inputs	Balance as of January 1, 2022 $ 6,526,129 Fair value at issuance - Loss on conversion of debt and change in derivative liability 1,568,898 Balance as of June 30, 2022 $ 8,095,027
Schedule of fair market value of derivative liability assumptions	June 30, 2022 Risk free interest rate 0.17% - 3.01 % Stock volatility factor 20.0% - 179.0 % Weighted average expected option life 6 months - 5 years Expected dividend yield None

Restricted Stock and Warrants (

Restricted Stock and Warrants (Tables)	6 Months Ended
	Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of warrant activity	June 30, 2022 Number of Weighted Outstanding - beginning of period 217,085,783 $ 0.0868 Granted 24,457,600 $ 0.1250 Exercised - - Expired (151,176,010 ) $ 0.0662 Outstanding - end of period 90,667,373 $ 0.1173
Schedule of weighted average remaining contractual life of warrants outstanding	June 30, 2022 Weighted Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.02 600,000 600,000 4.18 $ 0.05 25,200,000 25,200,000 0.67 $ 0.10 20,115,000 20,115,000 0.02 - 1.65 $ 0.25 10,006,000 10,006,000 1.25 – 4.50 $ 0.0275 8,727,273 8,727,273 8.92 $ 0.125 24,457,600 24,457,600 4.52 – 6.00 $ 1.00 1,561,500 1,561,500 2.00 - 2.47 90,667,373 90,667,373

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
Schedule of outstanding convertible promissory notes	Convertible Promissory Notes $ 3,012,155 Less current portion 878,283 Total long-term liabilities $ 2,133,872
Schedule of maturities of long-term debt	Year Ending June 30, Amount 2023 878,283 2024 2,120,100 2025 13,772 $ 3,012,155

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	6 Months Ended
	Jun. 30, 2022
Revenue from Contracts with Customers [Abstract]
Schedule of disaggregation of revenue by type of good or service from contracts with customers	Six Months Ended June 30, 2022 2021 Equipment Contracts $ 3,383,906 $ 1,181,981 Component Sales 677,963 500,234 Waste Water Treatment Systems 301,770 - Rental Income 13,146 14,687 Services Sales 25,287 30,698 $ 4,402,072 $ 1,727,600

Basis of Presentation (Details)

Basis of Presentation (Details)	6 Months Ended
	Jun. 30, 2022 USD ($)
Accounting Policies [Abstract]
Capital amount	$ 1,000,000
Revenue	$ 4,402,072

Summary of Significant Accoun_3

Summary of Significant Accounting Polices (Details) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Accounting Policies [Abstract]
Allowance for doubtful accounts	$0		$0
Contract receivable	$ 1,389,291		$ 2,150,967
Prepaid expenses	11,615		13,111
Depreciation expense	21,242	$ 23,131
Raw materials	$ 18,025		$ 2,850
Derivative term of contract	12 months

Summary of Significant Accoun_4

Summary of Significant Accounting Polices (Details) - Schedule of loss per share anti-dilutive effect - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Schedule of loss per share anti-dilutive effect [Abstract]
Income (Loss) to common shareholders (Numerator) (in Dollars)	$ (4,842,023)	$ (30,798,927)
Basic weighted average number of common shares outstanding (Denominator)	495,173,641	122,395,397
Diluted weighted average number of common shares outstanding (Denominator)	495,173,641	122,395,397

Summary of Significant Accoun_5

Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life	6 Months Ended
	Jun. 30, 2022
Machinery and equipment [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years
Machinery and equipment [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	10 years
Furniture, fixtures and computer equipment [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years
Furniture, fixtures and computer equipment [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	7 years
Vehicles [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	3 years
Vehicles [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years
Leasehold improvements [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	2 years
Leasehold improvements [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years

Summary of Significant Accoun_6

Summary of Significant Accounting Polices (Details) - Schedule of property plant and equipment - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	$ 603,373	$ 603,373
Less accumulated depreciation	(411,224)	(389,982)
Net Property and Equipment	192,149	213,391
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	383,569	383,569
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	62,854	62,854
Furniture [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	29,810	29,810
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	26,725	26,725
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	64,276	64,276
Demo Units [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	$ 36,139	$ 36,139

Summary of Significant Accoun_7

Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments	Jun. 30, 2022 USD ($)
Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments [Line Items]
Investment at fair value-securities	$ 67,813
Total Assets measured at fair value	67,813
Derivative Liabilities	8,095,027
Total liabilities measured at fair value	8,095,027
Level 1 [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments [Line Items]
Investment at fair value-securities	67,813
Total Assets measured at fair value	67,813
Derivative Liabilities
Total liabilities measured at fair value
Level 2 [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments [Line Items]
Investment at fair value-securities
Total Assets measured at fair value
Derivative Liabilities
Total liabilities measured at fair value
Level 3 [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments [Line Items]
Investment at fair value-securities
Total Assets measured at fair value
Derivative Liabilities	8,095,027
Total liabilities measured at fair value	$ 8,095,027

Summary of Significant Accoun_8

Summary of Significant Accounting Polices (Details) - Schedule of reconciliation of the derivative liability for which level 3 inputs	6 Months Ended
	Jun. 30, 2022 USD ($)
Schedule of reconciliation of the derivative liability for which level 3 inputs [Abstract]
Balance	$ 6,526,129
Fair value at issuance
Loss on conversion of debt and change in derivative liability	1,568,898
Balance	$ 8,095,027

Summary of Significant Accoun_9

Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions	6 Months Ended
	Jun. 30, 2022
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Expected dividend yield	0%
Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Risk free interest rate	0.17%
Stock volatility factor	20%
Weighted average expected option life	6 months
Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Risk free interest rate	3.01%
Stock volatility factor	179%
Weighted average expected option life	5 years

Capital Stock (Details)

Capital Stock (Details) - USD ($)																								1 Months Ended				6 Months Ended	12 Months Ended
	Aug. 08, 2022	Jul. 13, 2022	Jul. 05, 2022	Feb. 11, 2022	Dec. 06, 2021	Dec. 01, 2021	Nov. 12, 2021	Aug. 10, 2021	May 26, 2021	Apr. 28, 2021	Mar. 01, 2021	Feb. 24, 2021	Feb. 05, 2021	Nov. 16, 2020	Aug. 21, 2020	Jul. 01, 2020	Apr. 27, 2020	Jun. 03, 2019	Apr. 03, 2019	Jan. 16, 2019	Aug. 14, 2018	Apr. 13, 2018	Mar. 14, 2017	Apr. 25, 2022	Feb. 18, 2022	Jan. 18, 2022	Feb. 24, 2021	Jun. 30, 2022	Dec. 31, 2021	Aug. 10, 2022	Jun. 30, 2021	Apr. 30, 2021	Dec. 31, 2020
Capital Stock (Details) [Line Items]
Conversion of preferred shares			45,642,386																									1,557.847
Redeem shares																												432
Aggregate of shares																												432,150
Conversion of shares	3,028,099
Aggregate shares																														3,165,009
Common stock par value (in Dollars per share)																												$ 0.0001	$ 0.0001
Sale of property, description																												On September 13, 2021, the Company received an offer for the property for $464,000, which was $116,000 below the original independent appraisal of $580,000. Based on that indicator of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the long term asset for sale from $630,000 to $514,000 on the balance sheet and recorded an impairment of $116,000 in the consolidated financial statements.
Shares issued																												607,030,697	306,883,932
Warrants shares (in Dollars)																												$ 0.25
Preferred stock outstanding																												19,944
Trading days										5
Common stock shares outstanding																												607,030,697	306,883,932
Restricted cash (in Dollars)																												$ 1,066,391	$ 433,951
Common stock, shares, outstanding percentage				4.99%
Fair value (in Dollars)																												630,000
Aggregate principal amount (in Dollars)							$ 149,867
Interest amount (in Dollars)																												$ 52,555
Common stock issued for services, shares																												24,845,550
Common stock issued for services fair value (in Dollars)																												$ 522,535
Fair value (in Dollars)																												13,128
Aggregate principal amount (in Dollars)																												$ 25,000
Series I Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock, description																			Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I is not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock. The Company has the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series I between May 2, 2021 and June 10, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the six months ended June 30, 2022, the Company exchanged an aggregate of 210 shares of Series I preferred stock for 210 shares of Series W preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of June 30, 2022, there were 25 shares of Series I preferred stock issued and outstanding which the Company was required to, and failed to redeem between on June 10, 2021, and was and remains in default for an aggregate redemption price (equal to the stated value) of $25,000. Series J On April 3, 2019, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain make-good shares for certain prior investors. During the six months ended June 30, 2022, the Company issued an aggregate of 512,737 shares of common stock upon conversion of 5 shares of Series J preferred stock, for a loss in the amount of $5,203. As of June 30, 2022, there were 210 shares of Series J preferred stock issued and outstanding. Series K On June 3, 2019, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K is not entitled to any voting rights except as may be required by applicable law, and is not convertible into common stock. The Company has the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company is required to redeem such shares of Series K between August 5, 2021 and April 24, 2022, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the six months ended June 30, 2022, the Company exchanged an aggregate of 85 shares of Series K preferred stock for 85 shares of Series W preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. On January 18, 2022, the Company returned $63,500 to an investor, and redeemed 63.5 shares of Series K preferred stock. As of June 30, 2022, there were 432 shares of Series K preferred stock issued and outstanding which the Company was required to, and failed to redeem between August 5, 2021 and March 26, 2022, and was and remains in default for an aggregate redemption price (equal to the stated value) of $432,150. Series L On June 3, 2019, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series L COD, which includes certain make-good shares for certain prior investors. During the six months ended June 30, 2022, the Company issued an aggregate of 15,973,192 shares of common stock upon conversion of 134 shares of Series L preferred stock, for a loss in the amount of $240,782. As of June 30, 2022, there were 476 shares of Series L preferred stock issued and outstanding.    Series M On July 1, 2020, the Company designated 800,000 shares of its preferred stock as Series M. Each share of Series M has a stated value of $25. The Series M is not convertible into common stock. The holders of outstanding shares of Series M are entitled to receive dividends, at the annual rate of 10%, payable monthly, payable in preference and priority to any payment of any dividend on the common stock. The Series M is entitled to a liquidation preference in an amount equal to $25 per share plus any declared but unpaid dividends, before any payments to holders of common stock. The Series M have no pre-emptive or subscription rights, and there are no sinking fund provisions applicable to the Series M. The Series M does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the Certificate of Designation of Series M preferred stock. To the extent it may lawfully do so, the Company may, in its sole discretion, at any time when there are outstanding shares of Series M, redeem any or all of the then outstanding shares of Series M at a redemption price of $37.50 per share (150% of the stated value) plus any accrued but unpaid dividends. As of June 30, 2022, there were 40,300 shares of Series M preferred stock issued and outstanding. Series O On April 27, 2020, the Company designated 2,000 shares of preferred stock as Series O. The Series O has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series O has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series O. The Series O does not have voting rights except as required by law. The Series O is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series O being converted by the conversion price, provided that, the Series O may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series O at any time while the Series O are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the six months ended June 30, 2022, the Company issued an aggregate of 720,665 shares of common stock in prorated 4% annualized dividends which are recorded as interest expense. As of June 30, 2022, there were 615 shares of Series O preferred stock issued and outstanding.  Series P On April 27, 2020, the Company designated 500 shares of preferred stock as Series P. The Series P has a stated value of $1,000 per share, and entitles holders to receive dividends on an as-converted basis with the Company’s common stock. The Series P is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Certificate of Designation of Series P preferred stock, which includes certain make-good shares for certain prior investors, and provided that, the Series P may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Series P entitles the holders to a payment on an as-converted and pari passu basis with the common stock upon any liquidation. The Series P has no preemptive or subscription rights, and there is no sinking fund or redemption provisions applicable to the Series P. The Series P votes on an as-converted basis with the common stock, subject to the beneficial ownership limitation. As of June 30, 2022, there were 57.5 shares of Series P preferred stock issued and outstanding. Series Q On August 21, 2020, the Company designated 2,000 shares of preferred stock as Series Q. The Series Q has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series Q has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series Q has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series Q. The Series Q does not have voting rights except as required by law. The Series Q is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series Q being converted by the conversion price, provided that, the Series Q may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series Q at any time while the Series Q are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the six months ended June 30, 2022, the Company exchanged 200 shares of Series F preferred stock for 200 shares of Series Q preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized.
Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares outstanding																												33,038,213	33,038,213		33,038,213		34,038,213
Warrants shares (in Dollars)																												$ 28,217,600
Common Stock [Member]
Capital Stock (Details) [Line Items]
Shares outstanding																												607,030,697	306,883,932		180,137,993		65,052,688
Redeem shares																												12,461,909
Aggregate purchase price (in Dollars)																												$ 119,634
Common stock share issued																												12,461,909
Aggregate principal amount (in Dollars)																												$ 69,900
Interest amount (in Dollars)																												$ 49,734
Conversion price (in Dollars per share)																												$ 0.00955
Common stock issued for services, shares																												17,045,363
Common stock issued for services fair value (in Dollars)																												$ 1,437,369
Shares issued																												131,282,467
Common stock of convertible promissory notes																												13,927,622
Aggregate principal amount (in Dollars)																												$ 81,150
Maximum [Member]
Capital Stock (Details) [Line Items]
Conversion price (in Dollars per share)																												$ 0.0319
Share prices ranging (in Dollars per share)																												0.0351
Minimum [Member]
Capital Stock (Details) [Line Items]
Conversion price (in Dollars per share)																												0.0134
Share prices ranging (in Dollars per share)																												0.124
Minimum [Member] | Common Stock [Member]
Capital Stock (Details) [Line Items]
Conversion price (in Dollars per share)																												$ 0.00955
Series W Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Aggregate preferred stock, share issued																												210
Series C Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)																							$ 0.0001
Voting power																							51%
Purchase price of the series C preferred stock (in Dollars per share)																							$ 0.1
Total purchase price series C preferred stock, shares																							1,000
Preferred stock shares outstanding																												1,000
Preferred stock, share authorized																												550,000,000	550,000,000
Preferred stock and warrants																												1,000	1,000
Preferred stock per share (in Dollars per share)																												$ 0.0001	$ 0.0001
Preferred stock outstanding																												1,000	1,000
Series D-1 Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock, share authorized																						50,000,000
Convertible preferred stock, per share (in Dollars per share)																						$ 0.0005
Percentage of common stock outstanding																						4.99%
Increased common stock percentage																						9.99%
Preferred stock and warrants																												31,500,000
Preferred stock issued and outstanding																												31,500,000
Series E Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock, share authorized																					4,000,000
Convertible preferred stock, per share (in Dollars per share)																					$ 0.05
Percentage of common stock outstanding																					4.99%
Increased common stock percentage																					9.99%
Preferred stock and warrants																												1,537,213	1,537,213
Preferred stock issued and outstanding																												1,537,213
Preferred stock outstanding																												1,537,213	1,537,213
Issuance of common stock, shares																												83,777,463
Common stock upon conversion of preferred stock																												8,378
Series F Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock shares outstanding																													260
Designated preferred stock issued																					6,000
Preferred stock liquidation per share (in Dollars per share)																					$ 1,000
Annual rate percentage																					8%
Preferred stock, description																													a holder of 100 of such outstanding shares of Series F preferred stock, agreed that the Company would have no obligation to redeem such holder’s shares of Series F preferred stock prior to September 1, 2022. On February 14, 2022, the Company exchanged those 100 shares of the holder’s Series F preferred stock for 100 shares of Series Q preferred stock. During the six months ended June 30, 2022, the Company exchanged an additional 100 shares of Series F preferred stock for 100 shares of Series Q preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of June 30, 2022, the Company had 60 outstanding shares of Series F preferred stock, which the Company was required to, and failed to redeem on September 1, 2020, and was and remains in default for an aggregate redemption price (equal to the stated value) of $60,000.Series G On January 16, 2019, the Company designated 6,000 shares as Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. The Series G preferred stock does not have voting rights, except as required by law and is not convertible into common stock. The Company may, in its sole discretion, at any time while the Series G preferred stock is outstanding, redeem all or any portion of the outstanding Series G preferred stock at a price equal to the stated value plus any accrued but unpaid dividends. The Company was required to redeem such shares of Series G preferred stock on April 30, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser received shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. As of June 30, 2022, there were 25 shares of Series G preferred stock issued and outstanding, which the Company was required to, and failed to redeem on April 30, 2021, and was and remains in default for an aggregate redemption price (equal to the stated value) of $25,000. Series I On April 3, 2019, the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I is not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock. The Company has the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series I between May 2, 2021 and June 10, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the six months ended June 30, 2022, the Company exchanged an aggregate of 210 shares of Series I preferred stock for 210 shares of Series W preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of June 30, 2022, there were 25 shares of Series I preferred stock issued and outstanding which the Company was required to, and failed to redeem between on June 10, 2021, and was and remains in default for an aggregate redemption price (equal to the stated value) of $25,000.  Series J On April 3, 2019, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain make-good shares for certain prior investors. During the six months ended June 30, 2022, the Company issued an aggregate of 512,737 shares of common stock upon conversion of 5 shares of Series J preferred stock, for a loss in the amount of $5,203. As of June 30, 2022, there were 210 shares of Series J preferred stock issued and outstanding. Series K On June 3, 2019, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K is not entitled to any voting rights except as may be required by applicable law, and is not convertible into common stock. The Company has the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company is required to redeem such shares of Series K between August 5, 2021 and April 24, 2022, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the six months ended June 30, 2022, the Company exchanged an aggregate of 85 shares of Series K preferred stock for 85 shares of Series W preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. On January 18, 2022, the Company returned $63,500 to an investor, and redeemed 63.5 shares of Series K preferred stock. As of June 30, 2022, there were 432 shares of Series K preferred stock issued and outstanding which the Company was required to, and failed to redeem between August 5, 2021 and March 26, 2022, and was and remains in default for an aggregate redemption price (equal to the stated value) of $432,150. Series L On June 3, 2019, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series L COD, which includes certain make-good shares for certain prior investors. During the six months ended June 30, 2022, the Company issued an aggregate of 15,973,192 shares of common stock upon conversion of 134 shares of Series L preferred stock, for a loss in the amount of $240,782. As of June 30, 2022, there were 476 shares of Series L preferred stock issued and outstanding.    Series M On July 1, 2020, the Company designated 800,000 shares of its preferred stock as Series M. Each share of Series M has a stated value of $25. The Series M is not convertible into common stock. The holders of outstanding shares of Series M are entitled to receive dividends, at the annual rate of 10%, payable monthly, payable in preference and priority to any payment of any dividend on the common stock. The Series M is entitled to a liquidation preference in an amount equal to $25 per share plus any declared but unpaid dividends, before any payments to holders of common stock. The Series M have no pre-emptive or subscription rights, and there are no sinking fund provisions applicable to the Series M. The Series M does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the Certificate of Designation of Series M preferred stock. To the extent it may lawfully do so, the Company may, in its sole discretion, at any time when there are outstanding shares of Series M, redeem any or all of the then outstanding shares of Series M at a redemption price of $37.50 per share (150% of the stated value) plus any accrued but unpaid dividends. As of June 30, 2022, there were 40,300 shares of Series M preferred stock issued and outstanding. Series O On April 27, 2020, the Company designated 2,000 shares of preferred stock as Series O. The Series O has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series O has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series O. The Series O does not have voting rights except as required by law. The Series O is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series O being converted by the conversion price, provided that, the Series O may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series O at any time while the Series O are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the six months ended June 30, 2022, the Company issued an aggregate of 720,665 shares of common stock in prorated 4% annualized dividends which are recorded as interest expense. As of June 30, 2022, there were 615 shares of Series O preferred stock issued and outstanding.  Series P On April 27, 2020, the Company designated 500 shares of preferred stock as Series P. The Series P has a stated value of $1,000 per share, and entitles holders to receive dividends on an as-converted basis with the Company’s common stock. The Series P is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Certificate of Designation of Series P preferred stock, which includes certain make-good shares for certain prior investors, and provided that, the Series P may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Series P entitles the holders to a payment on an as-converted and pari passu basis with the common stock upon any liquidation. The Series P has no preemptive or subscription rights, and there is no sinking fund or redemption provisions applicable to the Series P. The Series P votes on an as-converted basis with the common stock, subject to the beneficial ownership limitation. As of June 30, 2022, there were 57.5 shares of Series P preferred stock issued and outstanding. Series Q On August 21, 2020, the Company designated 2,000 shares of preferred stock as Series Q. The Series Q has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series Q has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series Q has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series Q. The Series Q does not have voting rights except as required by law. The Series Q is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series Q being converted by the conversion price, provided that, the Series Q may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series Q at any time while the Series Q are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the six months ended June 30, 2022, the Company exchanged 200 shares of Series F preferred stock for 200 shares of Series Q preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized.
Aggregate preferred stock, share issued																												200
Series G Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																												25
Designated preferred stock issued																				6,000
Annual rate percentage																				8%
Preferred stock per share (in Dollars per share)																				$ 1,000
Divided closing price (in Dollars)																				$ (500)
Shares outstanding																																25,000
Series J Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)																			$ 1,000
Preferred stock issued and outstanding																												210
Designated preferred stock issued																			100,000
Issued shares																												512,737
Conversion of preferred shares																												5
Preferred stock loss amount (in Dollars)																												$ 5,203
Series K Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)																		$ 1,000
Preferred stock and warrants																												432.15	580.65
Designated preferred stock issued																		4,000
Redeemed shares																										63.5
Preferred stock outstanding																												432.15	580.65
Series K Preferred Stock [Member] | Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock and warrants																												85
Series M Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock issued and outstanding																												40,300
Designated preferred stock issued																800,000
Dividend rate, percentage																10%		8%
Stated value (in Dollars)																$ 25
Liquidation preference value (in Dollars)																$ 25
Redemption price, per share (in Dollars per share)																$ 37.5
Stated value percentage																150%
Series R Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																												3,034
Percentage of common stock outstanding														4.99%
Designated preferred stock issued														5,000
Preferred stock per share (in Dollars per share)														$ 1,000
Dividend rate, percentage														10%
Purchase price of shares																												85
Percentage of common stock														200%
Common stock outstanding increased percentage														9.99%
Aggregate purchase price																												28,625,607
Aggregate shares																												398
Exercise price (in Dollars per share)																												$ 0.05
Exercise price (in Dollars per share)																												$ 0.1
Series R Preferred Stock [Member] | Series A warrants [Member]
Capital Stock (Details) [Line Items]
Preferred warrants																												101,498,340
Series R Preferred Stock [Member] | Series B Warrants [Member]
Capital Stock (Details) [Line Items]
Preferred stock issued and outstanding																												49,177,670
Series W Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock and warrants										3,390
Annual rate percentage										12%
Preferred stock per share (in Dollars per share)										$ 1,000
Shares exchange																												85
Stated value percentage										200%
Outstanding common stock percentage										4.99%
Preferred stock issued and outstanding																												995
Series L Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)																		$ 1,000
Preferred stock issued and outstanding																												476
Designated preferred stock issued																		100,000
Conversion of preferred shares																												15,973,192
Preferred stock loss amount (in Dollars)																												$ 240,782
Conversion of shares																												134
Series O Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)																	$ 1,000
Preferred stock issued and outstanding																												615
Designated preferred stock issued																	2,000
Conversion of preferred shares																												720,665
Conversion price percentage																	200%
Aggregate preferred stock, share issued																												0.04
Series O Preferred Stock [Member] | Common Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																												334,857
Common stock for preferred stock dividends payable																												720,665
Series O Preferred Stock [Member] | Maximum [Member]
Capital Stock (Details) [Line Items]
Annual rate percentage																	8%
Outstanding common stock percentage																	9.99%
Series O Preferred Stock [Member] | Minimum [Member]
Capital Stock (Details) [Line Items]
Annual rate percentage																	4%
Outstanding common stock percentage																	4.99%
Series P Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Increased common stock percentage																	9.99%
Preferred stock issued and outstanding																												57.5
Designated preferred stock issued																	500
Preferred stock per share (in Dollars per share)																	$ 1,000
Percentage of common stock																	4.99%
Series Q Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Percentage of common stock outstanding															4.99%
Preferred stock issued and outstanding																												715
Designated preferred stock issued															2,000
Preferred stock per share (in Dollars per share)															$ 1,000
Dividend rate, percentage															12%
Percentage of common stock															200%
Common stock outstanding increased percentage															9.99%
Aggregate shares (in Dollars)																												$ 200
Series S Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)													$ 1,000
Percentage of common stock outstanding													4.99%
Increased common stock percentage													9.99%
Preferred stock issued and outstanding																												170
Designated preferred stock issued													430
Dividend rate, percentage													12%
Percentage of common stock													200%
Series T Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued												630															630
Preferred stock per share (in Dollars per share)												$ 1,000															$ 1,000
Percentage of common stock outstanding												4.99%
Preferred stock and warrants												25,200,000															25,200,000
Designated preferred stock issued												630															630
Dividend rate, percentage												10%
Common stock outstanding increased percentage												9.99%
Aggregate shares (in Dollars)																												$ 53,327,672
Aggregate shares																												344
Common stock par value (in Dollars per share)											$ 0.05
Annual dividends, percentage											10%
Real property cost (in Dollars)											$ 630,000
Property consists of residential real estate (in Dollars)											580,000
Undeveloped lots valued (in Dollars)											$ 50,000
Long term asset for sale (in Dollars)												$ 630,000															$ 630,000
Preferred stock valued (in Dollars)																											$ 2,037,849
Preferred stock issued and outstanding																												286
Series U Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Percentage of common stock outstanding									4.99%
Designated preferred stock issued									5,000
Preferred stock per share (in Dollars per share)									$ 1,000
Conversion of preferred shares																												210
Percentage of common stock									150%
Common stock outstanding increased percentage									9.99%
Aggregate shares																												22,794,493
Common stock par value (in Dollars per share)									$ 0.2
Conversion price percentage									200%
Shares issued																												432
Preferred stock and warrants																												635
Series U Preferred Stock [Member] | Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Warrants shares (in Dollars)																												$ 18,115,000
Series Y Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Percentage of common stock outstanding					4.99%
Increased common stock percentage					9.99%
Preferred stock and warrants																												635
Designated preferred stock issued					3,000
Conversion of preferred shares																								0.5
Shares exchange																												4
Conversion of shares		8.8
Aggregate shares																								4,230,769
Preferred stock outstanding																												34.8
Restricted cash																												2,185,700
Original issue price (in Dollars)					$ 100,000
Aggregate value of common stock (in Dollars)																												$ 4
Aggregate value (in Dollars)																												$ 400,000
Warrants issued																												3,200,000
Restricted cash (in Dollars)																												$ 4,371,400
Amount of accrued dividends (in Dollars)																												$ 371,863
Series A warrants [Member]
Capital Stock (Details) [Line Items]
Exercise price (in Dollars per share)																												$ 0.05
Series B Warrants [Member]
Capital Stock (Details) [Line Items]
Exercise price (in Dollars per share)																												$ 0.1
Warrants shares (in Dollars)																												$ 6,246,000
Series C warrants [Member]
Capital Stock (Details) [Line Items]
Exercise price (in Dollars per share)																												$ 1
Warrants shares (in Dollars)																												$ 1,561,000
Series V Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Percentage of common stock outstanding						4.99%
Designated preferred stock issued						3,000
Issued shares																												4
Shares exchange																												4
Common stock outstanding increased percentage						9.99%
Original issue price (in Dollars)						$ 100,000
Annual net profits percentage						25%
Subsidiary’s annual net profits percentage						25%
Fair value of original issuance (in Dollars)																												$ 3,200,000
Series I Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock and warrants																												25	797
Conversion of preferred shares																												45
Aggregate shares																												3,811,810
Preferred stock outstanding																												25	797
Series I Preferred Stock [Member] | Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock and warrants																												85
Series W Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Increased common stock percentage								9.99%
Preferred stock issued and outstanding																												25
Designated preferred stock issued								25
Stated value (in Dollars)								$ 10,000
Percentage of common stock								250%
Shares issued																												129,276,280
Common stock shares outstanding								0.0499
Subscription agreement percentage								125%
Subscribed amount (in Dollars)								$ 250,000
Original purchase price (in Dollars)								312,500
Common stock purchase price (in Dollars)								250,000
Divided price (in Dollars)								$ 625,000
Sale of aggregate shares								25
Aggregate purchase price (in Dollars)								$ 250,000
Restricted cash																												140,000
Restricted cash (in Dollars)																												$ 250,000
Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Exercise price (in Dollars per share)																												$ 862,651
Series Z Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Designated preferred stock issued				25
Annual rate percentage				25%
Conversion of preferred shares																												25
Common stock outstanding increased percentage				9.99%
Aggregate shares																									25
Original issue price (in Dollars)				$ 10,000
Preferred stock purchase price (in Dollars)																									$ 250,000
Number of warrants shares																									2,500,000
Fair value (in Dollars)																									$ 56,036
Securities Purchase Agreement [Member] | Series T Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Aggregate purchase price, shares											630
Agreed of purchase warrants											630
Number of acquire warrant shares											25,200,000
Board of Directors Chairman [Member] | Series C Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Shares issued																							1,000
Preferred stock per share (in Dollars per share)																							$ 0.0001
Investor [Member] | Series K Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock loss amount (in Dollars)																										$ 63,500

Restricted Stock and Warrants_2

Restricted Stock and Warrants (Details) - USD ($)		6 Months Ended
	Aug. 14, 2019	Jun. 30, 2022
Restricted Stock and Warrants (Details) [Line Items]
Restricted stock grant agreement, description		of up to 367,141,542 shares of the Company’s common stock to employees and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 183,570,771 shares of its common stock; b) If the Company’s consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC reports, the Company will issue up to an aggregate of 183,570,771 shares of its common stock. The Company has not recognized any costs associated with the milestones, because achievement is not probable.
Board of directors amendment, description	The Company then (i) calculates the value of the Company common stock traded in the year immediately prior to the vesting year, using daily adjusted close and volume, as quoted on the public securities trading market on which the Company’s common stock is then traded (ii) determines the cost basis of the shares, which shall be the closing price quoted on the public securities trading market, quoted on the first trading day of the vesting year which will be the grantee’s cost basis, and (iii) applies the 10% calculation and divides it into the number of qualifying alternate vestees, giving the gross number of shares available to each Grantee. For each alternate vestee for each year in which there occurs a vesting or a potential vesting, the Company (i) does a 90-day lookback from the first day of the latest vesting month, to limit cumulative vesting of shares for each alternate vestee for the 90-day period to 1% of total Company shares of common stock outstanding for the period, using the then current figure for shares outstanding at the time of the lookback; (ii) places the excess shares (the “Overlimit Shares”) in suspense for issuance in the next 90-day period so that in each future 90-day period they may be issued, and (iii) if on the 90-day lookback, cumulative issuances are less than 1% of shares outstanding, the Company will add the shares from previous 90-day lookback, if any. For the avoidance of doubt, the Company will not record any Overlimit Shares as vested until such as time as they have been finally issued.
Number of purchase of warrants		24,457,600
Warrants outstanding		$ 0
Restricted Stock Grant Agreement [Member] | Employee Consultants and Restricted Stock Grant Agreements [Member]
Restricted Stock and Warrants (Details) [Line Items]
Issuance of common stock to employees		367,141,542
Aggregate of common stock, percentage	10%
Chief Executive Officer [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Details) [Line Items]
Restricted stock grant agreement, description		The RSGAs provides for the issuance of up to an aggregate of 242,109,214 shares of the Company’s common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 121,054,607 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported in the Company’s SEC Reports, the Company will issue up to an aggregate of 121,054,607 shares of its common stock.

Restricted Stock and Warrants_3

Restricted Stock and Warrants (Details) - Schedule of warrant activity - Warrant [Member]	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Restricted Stock and Warrants (Details) - Schedule of warrant activity [Line Items]
Number of Warrants, Outstanding - beginning of period | shares	217,085,783
Weighted average exercise price, Outstanding - beginning of period | $ / shares	$ 0.0868
Number of Warrants, Granted | shares	24,457,600
Weighted average exercise price, Granted | $ / shares	$ 0.125
Number of Warrants, Exercised | shares
Weighted average exercise price, Exercised | $ / shares
Number of Warrants Expired | shares	(151,176,010)
Weighted average exercise price Expired | $ / shares	$ 0.0662
Number of Warrants, Outstanding - end of period | shares	90,667,373
Weighted average exercise price, Outstanding - end of period | $ / shares	$ 0.1173

Restricted Stock and Warrants_4

Restricted Stock and Warrants (Details) - Schedule of weighted average remaining contractual life of warrants outstanding	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Class of Warrant or Right [Line Items]
Warrants Outstanding	90,667,373
Warrants Exercisable	90,667,373
0.02 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.02
Warrants Outstanding	600,000
Warrants Exercisable	600,000
Weighted Average Remaining Contractual Life (years)	4 years 2 months 4 days
0.05 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.05
Warrants Outstanding	25,200,000
Warrants Exercisable	25,200,000
Weighted Average Remaining Contractual Life (years)	8 months 1 day
0.10 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.1
Warrants Outstanding	20,115,000
Warrants Exercisable	20,115,000
0.25 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.25
Warrants Outstanding	10,006,000
Warrants Exercisable	10,006,000
0.0275 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.0275
Warrants Outstanding	8,727,273
Warrants Exercisable	8,727,273
Weighted Average Remaining Contractual Life (years)	8 years 11 months 1 day
0.125 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.125
Warrants Outstanding	24,457,600
Warrants Exercisable	24,457,600
1.00 [Member]
Class of Warrant or Right [Line Items]
Exercisable Prices (in Dollars per share) | $ / shares	$ 1
Warrants Outstanding	1,561,500
Warrants Exercisable	1,561,500
Minimum [Member] | 0.10 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	7 days
Minimum [Member] | 0.25 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	1 year 3 months
Minimum [Member] | 0.125 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	4 years 6 months 7 days
Minimum [Member] | 1.00 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years
Maximum [Member] | 0.10 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	1 year 7 months 24 days
Maximum [Member] | 0.25 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	4 years 6 months
Maximum [Member] | 0.125 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	6 years
Maximum [Member] | 1.00 [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 5 months 19 days

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)			1 Months Ended	6 Months Ended
	Jan. 25, 2021	Mar. 13, 2019	Nov. 19, 2020	Jun. 30, 2022	May 31, 2018	Apr. 02, 2018
Convertible Promissory Notes (Details) [Line Items]
Share issued (in Shares)				432
Accrued interest				$ 49,734
Aggregate remaining amount				25,000
Aggregate remaining amount				1,200,000
Aggregate remaining amount short term				$ 1,200,000
Convertible debt		$ 570,000
Maturity date				Nov. 19, 2021
Penalty Per day				$ 2,000
Derivative liabilities				$ 8,095,027
Common Stock [Member]
Convertible Promissory Notes (Details) [Line Items]
Share issued (in Shares)				12,461,909
Conversion of common stock				$ 69,900
Aggregate remaining amount				$ 81,150
Unsecured Convertible Promissory Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description				The Apr & May 2018 Notes had maturity dates of April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per year. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty-five (25) trading days prior to conversion.
Aggregate remaining amount				$ 218,064	$ 300,000	$ 300,000
Investor amount		$ 570,000
Reserved shares (in Shares)		2,630,769
Unsecured Convertible Promissory Note [Member] | 2014-2015 Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description				The 2014-2015 Notes bear interest at 10% per year. The maturity dates were extended to November 2023 through April 2024. The 2014-2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes.
Aggregate remaining amount				$ 860,100
Unsecured Convertible Promissory Note [Member] | 2015-2016 Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description				The 2015 Notes are convertible into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015 Notes.
Debt instrument interest rate				10%
Unsecured Convertible Promissory Note [Member] | Nov 20 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				$ 13,772
Convertible debt			$ 50,000
Convertible debt received funds			$ 50,000
Bears interest rate			10%
Unsecured convertible promissory note, description			The Nov 20 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Nov 20 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. As of June 30, 2022, the remaining balance on the Nov 20 Note was $13,772, which is long term.The Company entered into an unsecured convertible promissory note (the “Jan 21 Note”), on January 25, 2021 in the amount of $60,000. The Company received funds in the amount of $60,000. The Jan 21 Note had an original maturity date of January 25, 2022 and was extended for an additional sixty (60) months from the maturity date. The Jan 21 Note bears interest at 10% per year. The Jan 21 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower of (a) $0.05 per share, (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted.
Unsecured Convertible Promissory Note [Member] | Jan 21 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Convertible debt	$ 60,000
Convertible debt received funds	$ 60,000
Unsecured convertible promissory note, description	The Jan 21 Note bears interest at 10% per year. The Jan 21 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower of (a) $0.05 per share, (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted.
Interest expense				3,743
Remaining debt amount				$ 60,000
Original Issue Discount [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description				After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date.
Aggregate remaining amount				$ 184,124
Accrued interest				13,334
Conversion into common stock				30,620
Long term promissory notes				62,275
Convertible Debt [Member] | Dec 2015 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				167,048
Accounts payable				$ 432,048
Percentage of average of lowest closing prices				75%
Convertible Debt [Member] | Sep 2016 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				$ 430,896
Accounts payable				$ 430,896
Percentage of average of lowest closing prices				75%

Convertible Promissory Notes _2

Convertible Promissory Notes (Details) - Schedule of outstanding convertible promissory notes	Jun. 30, 2022 USD ($)
Schedule of outstanding convertible promissory notes [Abstract]
Convertible Promissory Notes	$ 3,012,155
Less current portion	878,283
Total long-term liabilities	$ 2,133,872

Convertible Promissory Notes _3

Convertible Promissory Notes (Details) - Schedule of maturities of long-term debt	Jun. 30, 2022 USD ($)
Schedule of maturities of long-term debt [Abstract]
2023	$ 878,283
2024	2,120,100
2025	13,772
Total	$ 3,012,155

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Revenue from Contracts with Customers [Abstract]
Contract assets	$ 1,103,907	$ 378,932
Contract liability	$ 1,597,997	$ 1,886,946

Revenue from Contracts with C_4

Revenue from Contracts with Customers (Details) - Schedule of disaggregation of revenue by type of good or service from contracts with customers - Type of Good or Service [Member] - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Disaggregation of Revenue [Line Items]
Equipment Contracts	$ 3,383,906	$ 1,181,981
Component Sales	677,963	500,234
Waste Water Treatment Systems	301,770
Rental Income	13,146	14,687
Services Sales	25,287	30,698
Total	$ 4,402,072	$ 1,727,600

Financial Assets (Details)

Financial Assets (Details) - USD ($)			3 Months Ended	6 Months Ended
	Nov. 12, 2021	May 15, 2018	Mar. 31, 2022	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Interest and fees	$ 15,988
Aggregate amount	$ 149,867
Converted common stock (in Shares)	45,208,649
Investment in securities in fair value amount			$ 67,813
Unrealized gain			$ 131,105
Fair value investment in securities description		the Company received 4,000 shares of Water Technologies International, Inc. (“WTII”) Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into one thousand (1,000) shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition.
Preferred shares fair value				$ 6,000

Loans Payable (Details)

Loans Payable (Details) - USD ($)		1 Months Ended	6 Months Ended	12 Months Ended
	Sep. 12, 2020	Apr. 30, 2020	Jun. 30, 2022	Dec. 31, 2021
Loans Payable (Details) [Line Items]
Company received settlement amount			$ 25,000
Accounts payable			50,000
Net balance			$ 30,646
Proceeds from loans received		$ 505,000
Granted loan amount	$ 10,000
Secured Loans Payable [Member]
Loans Payable (Details) [Line Items]
Leaving balance description			short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. As of December 31, 2020, the finance cost was fully amortized. During the year ended December 31, 2021, the Company settled the majority of the loans in the amount of $262,250, of which $157,250 was recognized on the statement of operations as a gain on write-off of loan payable. The term of the loans ranged from two months to six months.
Paycheck Protection Program Loan [Member]
Loans Payable (Details) [Line Items]
Proceeds from loans received	$ 345,000
Economic Injury Disaster Loan [Member]
Loans Payable (Details) [Line Items]
Proceeds from loans received				$ 345,000
Granted loan amount		$ 150,000		$ 10,000

Capital Leases (Details)

Capital Leases (Details)	6 Months Ended
	Jun. 30, 2022 USD ($) $ / shares
Capital Leases [Abstract]
Capital lease term	60 months
Monthly payments for lease	$ 757
Lease price (in Dollars per share) | $ / shares	$ 1
Capital leases current balance	$ 3,441

Assets Held For Sale (Details)

Assets Held For Sale (Details)	6 Months Ended
	Jun. 30, 2022 USD ($)
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
Preferred stock fair value	$ 630,000
Fair value adjusted	116,000
Leaving a fair value	$ 514,000

Commitments and Contingencies (

Commitments and Contingencies (Details)	Jun. 30, 2022 USD ($) m²	Mar. 13, 2019 USD ($)
Commitments and Contingencies (Details) [Line Items]
Monthly rent	$ 7,900
Warrant reserve	$ 20,000
Convertible notes		$ 570,000
Mckinney [Member]
Commitments and Contingencies (Details) [Line Items]
Area of land (in Square Meters) | m²	12,000

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)

1 Months Ended

6 Months Ended

Aug. 12, 2022

Aug. 08, 2022

Aug. 05, 2022

Aug. 01, 2022

Jul. 29, 2022

Jul. 26, 2022

Jul. 20, 2022

Jul. 13, 2022

Jul. 08, 2022

Jul. 06, 2022

Jul. 05, 2022

Apr. 25, 2022

Jun. 30, 2022

Aug. 10, 2022

Jul. 21, 2022

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

45,642,386

1,557.847

Aggregate converted shares

3,028,099

Aggregate shares issued

432

Aggregate of shares

3,165,009

Warrant [Member]

Subsequent Events (Details) [Line Items]

Aggregate of shares (in Dollars)

$ 4,320,000

Series Y Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

0.5

Aggregate converted shares

8.8

Aggregate of shares

4,230,769

Series Y Common Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

70,931,416

Series Q Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares issued

100

Series Q Common Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

12,642,226

Series W Common Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

12,642,226

Series T Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate of shares (in Dollars)

$ 53,327,672

Aggregate of shares

344

Series L Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

15,973,192

Aggregate converted shares

134

Series R Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate of shares

398

Series I Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

45

Aggregate of shares

3,811,810

Series J Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

5

Subsequent Event [Member] | Series Y Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

5.4

27,438,605

5.4

Aggregate purchase price (in Dollars)

$ 540,000

$ 540,000

Aggregate converted shares

150,912

Subsequent Event [Member] | Series E Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate converted shares

1,537,213

Subsequent Event [Member] | Series E Common Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

76,865

Subsequent Event [Member] | Series W Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate converted shares

1,023,192

100

Aggregate of shares

3,165,009

Subsequent Event [Member] | Series T Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate converted shares

409,518

Subsequent Event [Member] | Series L Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

106,496

Aggregate converted shares

1

Subsequent Event [Member] | Series R Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

29,777,778

Aggregate converted shares

268

Subsequent Event [Member] | Series I Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate converted shares

1

Subsequent Event [Member] | Series J Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate converted shares

25